US20230270517A1 - Tissue expanders and methods of use thereof - Google Patents
Tissue expanders and methods of use thereof Download PDFInfo
- Publication number
- US20230270517A1 US20230270517A1 US18/084,041 US202218084041A US2023270517A1 US 20230270517 A1 US20230270517 A1 US 20230270517A1 US 202218084041 A US202218084041 A US 202218084041A US 2023270517 A1 US2023270517 A1 US 2023270517A1
- Authority
- US
- United States
- Prior art keywords
- ridges
- expander
- medical device
- implantable medical
- shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title abstract description 23
- 238000012876 topography Methods 0.000 claims abstract description 12
- 230000008602 contraction Effects 0.000 claims abstract description 10
- 239000012530 fluid Substances 0.000 claims description 46
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 229920002635 polyurethane Polymers 0.000 claims description 13
- 239000004814 polyurethane Substances 0.000 claims description 13
- 239000000560 biocompatible material Substances 0.000 claims description 11
- -1 polyethylene terephthalate Polymers 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 229920002614 Polyether block amide Polymers 0.000 claims description 4
- 241000217377 Amblema plicata Species 0.000 claims description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 3
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 3
- 229920000299 Nylon 12 Polymers 0.000 claims 1
- 239000013013 elastic material Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000011257 shell material Substances 0.000 description 117
- 210000001519 tissue Anatomy 0.000 description 63
- 239000000463 material Substances 0.000 description 24
- 239000007943 implant Substances 0.000 description 17
- 239000002245 particle Substances 0.000 description 15
- 210000000481 breast Anatomy 0.000 description 13
- 238000003780 insertion Methods 0.000 description 12
- 230000037431 insertion Effects 0.000 description 12
- 239000006185 dispersion Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 8
- 238000009826 distribution Methods 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 206010033675 panniculitis Diseases 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 210000004304 subcutaneous tissue Anatomy 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000004073 vulcanization Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 229910000851 Alloy steel Inorganic materials 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 229910000599 Cr alloy Inorganic materials 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- 229910001182 Mo alloy Inorganic materials 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910000756 V alloy Inorganic materials 0.000 description 1
- 229920006099 Vestamid® Polymers 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- INJRKJPEYSAMPD-UHFFFAOYSA-N aluminum;silicic acid;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O INJRKJPEYSAMPD-UHFFFAOYSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000000788 chromium alloy Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002283 elective surgery Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229910052850 kyanite Inorganic materials 0.000 description 1
- 239000010443 kyanite Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- VPRUMANMDWQMNF-UHFFFAOYSA-N phenylethane boronic acid Chemical compound OB(O)CCC1=CC=CC=C1 VPRUMANMDWQMNF-UHFFFAOYSA-N 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001175 rotational moulding Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 229910052854 staurolite Inorganic materials 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229910001773 titanium mineral Inorganic materials 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052845 zircon Inorganic materials 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/02—Devices for expanding tissue, e.g. skin tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
- A61B17/22032—Gripping instruments, e.g. forceps, for removing or smashing calculi having inflatable gripping elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0009—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed in or outside the body opening close to the surface of the body
- A61F2/0013—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed in or outside the body opening close to the surface of the body inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
- B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
- B29C41/04—Rotational or centrifugal casting, i.e. coating the inside of a mould by rotating the mould
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
- B29C41/34—Component parts, details or accessories; Auxiliary operations
- B29C41/38—Moulds, cores or other substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
- B29C41/34—Component parts, details or accessories; Auxiliary operations
- B29C41/42—Removing articles from moulds, cores or other substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
- B29C41/34—Component parts, details or accessories; Auxiliary operations
- B29C41/46—Heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
- A61B2017/00557—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00792—Plastic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00796—Breast surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0061—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
Definitions
- the present disclosure relates generally to implantable medical devices such as tissue expanders and methods of use thereof.
- Implants may be useful to correct natural asymmetries in body shape, to adjust the size and/or shape of certain features, or for post-operative reconstruction.
- a breast prosthesis may be used to augment or decrease the size of the breast, or to correct asymmetry in breast shape or volume following surgery, such as a mastectomy or partial mastectomy to remove cancerous breast tissue.
- a sizer or tissue expander Prior to implantation of a prosthesis, a sizer or tissue expander may be inserted temporarily to help to create or maintain the space necessary for the more permanent prosthesis. Keeping living tissues under tension by means of a tissue expander can promote formation of new tissue. As the tissue expander is enlarged over time, the surrounding tissues can expand to the point where the prosthesis may be implanted. Tissue expanders also may be used to spur the growth of new skin and subcutaneous tissue in other parts of the body.
- FIGS. 1 A and 1 B show an exemplary device, according to some aspects of the present disclosure.
- FIGS. 2 A and 2 B show another exemplary device, according to some aspects of the present disclosure.
- FIGS. 3 A and 3 B show a further exemplary device
- FIG. 3 C shows a mold for the device, according to some aspects of the present disclosure.
- FIG. 4 shows an exemplary system, according to some aspects of the present disclosure.
- FIG. 5 is a flow diagram showing an exemplary method by which an expander may be made, according to the present disclosure.
- FIGS. 6 A, 6 B, and 6 C show three states of expansion of the exemplary device of FIGS. 1 A and 1 B .
- a tissue expander having a flexible shell.
- the shell defines a cavity therein, and includes a plurality of ridges that curve along a surface of the shell about an axis, each ridge having a width and a length longer than the width.
- the shell includes an anterior side and a posterior side, the anterior side having an apex, wherein each ridge of the plurality of ridges is disposed circumferentially around the apex.
- the plurality of ridges includes a first annular ridge and a second annular ridge concentric with the first annular ridge.
- the plurality of curved ridges includes at least one channel connecting two adjacent ridges.
- the at least one channel includes two channels each extending radially outward, the two channels being disposed at least 45° apart about a circumference of the shell.
- the plurality of ridges includes a first ridge and a second ridge, the shell further including a plurality of channels connecting the first ridge and the second ridge, wherein the plurality of channels are circumferentially disposed at intervals around an apex of the shell.
- the plurality of ridges includes at least three ridges each separated from an adjacent ridge by a valley.
- the at least three ridges are disposed circumferentially around an apex of the shell, and the plurality of channels comprises, a first channel connecting the first ridge to the second ridge and traversing the valley between them; and a second channel connecting the second ridge to the third ridge and traversing the valley between them.
- the first channel, the second channel, and the apex are not co-linear. In some such embodiments, the first channel does not connect to the third ridge.
- the shell of the tissue expander is flexible and comprises silicone, polyurethane, or a copolymer thereof. In some embodiments, the shell has a uniform thickness ranging from about 0.3 mm to about 0.6 mm. In further embodiments, at least one of the anterior side or the posterior side of the shell is textured. In further embodiments, the tissue expander includes a port connector coupled to the shell.
- a tissue expander including a flexible shell defining a cavity therein.
- the shell includes a plurality of ridges, each ridge curving along a surface of the shell around an apex, and each ridge having a width and a length longer than the width.
- the shell also includes a channel connecting at least two of the ridges, and the shell has a uniform thickness.
- the channel is a first channel
- the shell further includes a second channel connecting at least two of the ridges.
- the plurality of ridges includes at least three concentric ridges.
- the shell includes a plurality of channels, each channel connecting only two adjacent ridges of the plurality of ridges.
- the tissue expander includes a port connector integrated into a portion of the shell.
- aspects of the present disclosure also include a tissue expander having a flexible shell defining a cavity therein, where the shell includes a plurality of parallel ridges that curve along a surface of the shell, each ridge having a width and a length longer than the width, and a plurality of channels extending radially outward, each channel connecting at least two adjacent ridges of the plurality of ridges.
- the plurality of channels are disposed in a staggered configuration.
- the tissue expander has a circular, oval, rectangular, spherical, crescent, or teardrop cross-sectional shape.
- the plurality of parallel ridges comprises concentric ridges on an anterior surface of the shell, and the shell is configured to distribute force applied to the anterior surface radially outward.
- the plurality of channels comprises at least three channels arranged into rows and spaced at regular intervals.
- aspects of the present disclosure also include a method of making a tissue expander.
- the method includes coating a mold with a liquid dispersion to form a shell, the mold including a plurality of circumferential grooves, curing the shell, and removing the shell from the mold, wherein the shell includes a plurality of ridges corresponding to the plurality of circumferential grooves of the mold.
- the liquid dispersion comprises silicone, polyurethane, or a mixture thereof.
- the method further includes inverting the shell such that the plurality of ridges are disposed on an outermost surface of the shell.
- the shell has a uniform thickness ranging from about 0.3 mm to about 0.6 mm.
- tissue expander mold includes: a body including a plurality of circumferential grooves, each groove curving along a surface of the body about a center axis of the body, each groove having a width and a length longer than the width, and a depression connecting at least two of the grooves.
- the plurality of grooves includes at least three grooves that curve parallel to each other around an apex of the body.
- the surface of the body is texturized.
- the terms “comprises,” “comprising.” or any other variation thereof are intended to cover a non-exclusive inclusion, such that a process, method, composition, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such process, method, composition, article, or apparatus.
- the term “exemplary” is used in the sense of “example” rather than “ideal.”
- the term “posterior” refers to the back of a patient, and the term “anterior” refers to front of a patient.
- the posterior side of a breast implant is the side of the implant facing the chest wall, while the anterior side is the opposite side closest to the skin.
- the posterior side of a gluteal or buttock implant is the side closest to the skin, and the anterior side is the opposite side facing the pelvis.
- Tissue expanders may be used to stretch or promote growth of tissue in a patient in preparation for an implant.
- a surgeon may place a tissue expander in a mastectomy patient as part of reconstructive repair of breast tissue.
- Tissue expanders generally include a fill port to allow for introduction of a liquid or gel (e.g., saline solution or other biocompatible liquid or gel) over time.
- the prosthesis is typically implanted into the breast cavity in an empty or only partially filled state.
- the implant may then be inflated to its desired size via a valve or fill port. Gradual inflation at pre-determined intervals may cause the skin and subcutaneous tissues overlying the expander to expand in response to the pressure exerted upon the tissue as the liquid or gel is introduced into the tissue expander.
- the skin and subcutaneous tissue may expand to the point where further medical procedures can be performed, such as the permanent implantation of a prosthesis, plastic and reconstructive surgery, or for use of the skin and subcutaneous tissue for use in some other part of the body.
- Volume adjustment may be beneficial, e.g., to make a later adjustment of size without having to replace the prosthesis with one of a different size, which would require a subsequent surgical procedure.
- Tissue expansion may occur over the span of weeks to months, e.g., from about 4 weeks to about 24 weeks, or from about 6 weeks to about 8 weeks, e.g., about 4, 6, 8, 10, 12, 14, or 16 weeks or more.
- Tissue expanders may comprise a flexible shell that allows for their expansion and contraction, e.g., upon introduction and removal, respectively, of a fluid in a cavity defined by the shell.
- a shell of a tissue expander may have a shape and topography that facilitates uniform or substantially uniform expansion of the tissue expander.
- the topography of a tissue expander shell may promote an even distribution of force of fluid within the tissue expander against the inner surface of the shell as the fluid is introduced into the shell.
- the topography of the shell may also promote an even distribution of force of the outer surface of the tissue expander against surrounding tissue, even as the device expands and changes sizes.
- the topography of the shell may promote retention of the shell's shape, with or without fluid inside, by discouraging wrinkling or unwanted folding of the shell.
- Tissue expanders may be implanted in a patient for a number of weeks or months, e.g., from about 4 weeks to about 8 months, or from about 6 weeks to about 6 months, e.g., about 4, 6, 8, 10, 12, 14, 16, 20, or 24 weeks or more.
- the shell may have an approximately uniform thickness.
- the shell may have a thickness that is greater on one side than the other (e.g., a posterior side of the shell may be thicker than an anterior side of the shell), or within different areas or regions of the shell.
- the thickness of the shell may range from about 0.1 mm to about 1.2 mm, such as from about 0.2 mm to about 0.8 mm, from about 0.3 mm to about 1.1 mm, from about 0.3 mm to about 0.4 mm, or from about 0.4 mm to about 0.6 mm.
- the thickness of the shell may range from about 0.33 mm to 1.02 mm, e.g., a thickness of about 0.35 mm, about 0.4 mm, about 0.45 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, or about 1.0 mm.
- the shell may have a uniform thickness ranging from about 0.4 mm to about 0.6 mm.
- the shell may include a series of features, such as grooves, canals, protrusions (e.g., rounded or folded ridges), pleats, creases, or folds, that allow the device to expand uniformly (e.g., similar to a bellows), promote even distribution of force of the device against surrounding tissue in which the device is implanted, and/or promote retention of the device's shape when both expanded and contracted.
- the configuration of the shell may help to control the way forces are applied to the device and/or to accommodate changes in volume while minimizing or avoiding wrinkling, bending, or twisting of the shell.
- these features may have a curved or wavy cross sectional profile.
- the shell may include a series of concentric curved pleats, having an approximately sinusoidal or wavy cross-sectional profile.
- FIGS. 1 A- 1 B, 2 A- 2 B, 3 A- 3 B, and 4 illustrate various examples of tissue expanders having features that provide for such expansion characteristics. While aspects of the present disclosure may be described in the context of a given type of tissue expander, such as, for example, an expander for placement in breast tissue, embodiments of the present disclosure may be, and/or may be applied to, a variety of medical procedures. Non-limiting examples include expanders prior to placement of other body contour implants such as gluteal, calf, etc., as well as to promote growth of skin or other tissue for various reconstructive or transplantation surgeries. For example, the tissue expanders herein may be used for skin regeneration. e.g., in order to replace damaged tissue, including scarred or burned tissue.
- the shell may comprise a biocompatible material or combination of biocompatible materials that allow the shell to flex.
- the material(s) may be elastic, such that the shell may retain its integrity after expansion and/or repeated cycles of expansion and contraction.
- Exemplary materials suitable for the shell include, but are not limited to, elastic polymers and copolymers, such as, e.g., silicone, polyurethane, polyurethane blends, silicone/polyurethane polymers and copolymers, polyethylene terephthalate (PET), polyether block amide (PEBA, e.g., Pebax®), and polyanude 12 (e.g., Grilamid® and Vestamid®).
- elastic polymers and copolymers such as, e.g., silicone, polyurethane, polyurethane blends, silicone/polyurethane polymers and copolymers, polyethylene terephthalate (PET), polyether block amide (PEBA, e.g., Pebax®), and
- the shell or shell material may have an elongation value between about 350% and about 900%, such as between about 400% and about 850%, between about 450% and about 850%, between about 450% and about 750%, between about 450% and about 650%, or between about 500% and about 600%, e.g., about 350%, about 400%, about 450%, about 500%, about 550%, about 600%, about 650%, about 700%, about 750%, or about 800% Additionally or alternatively, the shell or shell material may have a hardness between about 15 and about 95 (Shore A durometer), such as between about 25 and about 35, between about 25 and about 50, between about 30 and about 60, between about 40 and about 70, between about 50 and about 80, or between about 60 and about 90, e.g., about 20, about 25, about 30, about 35, about 40, about 45, about 50, about 55, about 60
- tissue expanders Any suitable fluid may be introduced and/or removed from the tissue expanders herein, such as, e.g., water, saline solution (or other biocompatible solution), silicone gel (or other biocompatible gel), or air (or other biocompatible gas, e.g., nitrogen).
- saline solution or other biocompatible solution
- silicone gel or other biocompatible gel
- air or other biocompatible gas, e.g., nitrogen
- the outer and/or inner surface of the shell may be texturized.
- the outer and/or inner surface of the shell may include any combination of surface features (e.g., roughness, skewness, kurtosis, peak height, valley depth, and/or contact point density values) that provide a surface texture or multiple surface textures as disclosed in U.S. Provisional Application No. 62/334,667 filed on May 11, 2016, and/or U.S. Provisional Application No. 62/410,121 filed on Oct. 19, 2016, each of which is incorporated by reference herein in its entirety.
- all or a portion of the outer surface of the tissue expander may have an average roughness (Sa) of 4.0 ⁇ m ⁇ 2 ⁇ m, a skewness value of 0.6 ⁇ 0.4, kurtosis value of 3.5 ⁇ 0.5, a maximum peak height of 14 ⁇ m ⁇ 2 ⁇ m, a maximum valley depth of 12 ⁇ m ⁇ 2 ⁇ m, and a contact point density ranging from 20,000 peaks/cm 2 to 60,000 peaks/cm 2 , such as from 45,000 peaks/cm 2 to 55,000 peaks/cm 2 .
- Such texturization may be provided by use of a texturized mold, as is further described elsewhere herein.
- FIGS. 1 A and 1 B illustrate an exemplary tissue expander 100 comprising a shell 105 having an anterior side 102 a and a posterior side 102 b .
- FIG. 1 A depicts a top-down view of expander 100
- FIG. 1 B depicts a side view of expander 100 .
- Expander 100 may be useful for preparing a pocket, e.g., a subglandular pocket or a submuscular pocket, in the chest tissue of a patient prior to insertion of an implant.
- Expander 100 may include a series of topographical features such as ridges 104 a , 104 b , 104 c and valleys 106 a , 106 b , 106 c on the anterior side 102 a and/or the posterior side 102 b , defining the surface of expander 100 .
- the expander 100 may also include a port connection 110 , which may fluidly connect the interior of expander 100 to a port, such as port 470 depicted in FIG. 4 (further discussed below).
- shell 105 may define an expandable cavity or bladder, wherein port 470 allows for introduction and/or removal of a fluid that provides for the expansion or contraction of expander 100 .
- Expander 100 may have a size and shape suitable for preparing a pocket or cavity in the chest tissue of a patient for receiving a breast implant. Expander 100 may have, for example, a generally circular cross-sectional area, including a circular posterior side 102 b , suitable for contacting the wall of a patient's chest cavity. The cross-sectional area may decrease from posterior side 102 b to anterior side 102 a , such that, upon expansion, expander 100 may have an arched or dome-like shape, similar to the shape of a breast or breast implant. Expander 100 may be expandable in the anterior-posterior direction (i.e., such that anterior side 102 a moves away from posterior side 102 b ) upon introduction of fluid into expander 100 . Likewise, expander 100 may be contractible in the anterior-posterior direction (i.e., such that anterior side 102 a moves away from posterior side 102 b ) upon removal of fluid from within expander 100 .
- a generally circular cross-sectional area including a
- Ridges 104 a , 104 b , 104 c and valleys 106 a . 106 b . 106 c , 106 d may be arranged so as to promote retention of expander 100 's shape, and/or uniform expansion and contraction of expander 100 .
- ridges 104 a may be arranged so as to promote retention of expander 100 's shape, and/or uniform expansion and contraction of expander 100 .
- 104 b , 104 c may be circular or otherwise rounded (e.g., oval) ridges arranged in a concentric pattern radiating outward from a point (e.g., a center point) on anterior side 102 a , and may be disposed in an alternating arrangement with circular or otherwise rounded (e.g., oval) valleys 106 a , 106 b , 106 c between adjacent ridges and/or between a ridge and the upper or lower portion of shell 105 .
- the centermost portion of anterior side 102 a may have a curved, convex shape that transitions radially outward into a valley 106 a , followed by a ridge 104 a , and so on.
- ridges 104 a , 104 b , 104 c may each have a height that is slightly greater than a depth of each of valleys 106 a , 106 b , 106 c , 106 d , such that expander 100 , upon expansion, assumes a domed shape where the center of anterior side 102 a is at an apex of the dome.
- Each ridge and valley may follow a continuous, circular path about the center of anterior side 102 a , e.g., as shown in FIGS. 1 A and 1 B , each ridge or valley having a uniform height or depth.
- one or more of the ridges and/or valleys may not be continuous about the surface of the shell.
- the expander may include channels and/or bridges between adjacent ridges or valleys (see. e.g., FIGS. 2 A- 2 B, 3 A- 3 B, and 4 , discussed below).
- expander 100 may include more or fewer ridges and valleys than are depicted in FIGS. 1 A and 1 B .
- expander 100 may include two, three, five, six, seven, or more ridges and/or valleys.
- the configuration of ridges and valleys may allow for each ridge to expand and/or collapse independently of the other ridges. It will be apparent to one of ordinary skill in the art that any suitable number of ridges and/or valleys may be included so as to promote uniform expansion and contraction of expander 100 , promote uniform exertion of outward force by expander 100 against surrounding tissue, and/or promote retention of the shape of expander 100 .
- a suitable number of ridges and/or valleys may be included to provide structure to expander 100 , such that when compressive force is applied to and/or fluid is removed from expander 100 , expander 100 collapses, if at all, along the lines of the ridges and valleys, thus controlling, preventing, or reducing wrinkles in expander 100 .
- the ridges may allow shell 105 to stretch in a manner so as to accommodate changes in volume without wrinkling of shell 105 .
- Port connection 110 may be situated in an opening in shell 105 , and may be configured to fluidly connect to, e.g., a lumen or a port, through which fluid may be introduced into and/or removed from expander 100 . Port connection 110 may be secured in the opening in shell 105 . In some embodiments, port connection 110 may be sealed to shell 105 , by, e.g., vulcanization or glue, adhered using, e.g., heat, such that fluid may not enter or exit expander 100 except for through port connection 110 .
- port connection 110 may comprise an integral portion of shell 105 , e.g., wherein port connection 110 may be molded together with shell 105 to form a one piece component of expander 100 , such that fluid enters and exits expander 100 only through port connection 110 .
- FIGS. 2 A and 2 B illustrate an exemplary tissue expander 200 comprising a shell 205 having an anterior side 202 a and a posterior side 202 b .
- Expander 200 may be similar to expander 100 and include any of the features of expander 100 —for example, expander 200 may have a general size and shape similar to that of expander 100 .
- Expander 200 may include ridges 204 a , 204 b , 204 c , 204 d , 204 e having shapes and configurations similar to ridges 104 a , 104 b , 104 c , as well as valleys 206 a , 206 b , 206 c , 206 d having shapes and configurations similar to valleys 106 a , 106 b , 106 c , 106 d . Expander 200 may also include a port connection 210 similar to port connection 110 .
- expander 200 may include features that connect ridges and/or valleys on the anterior side and/or posterior side of the shell.
- expander 200 includes channels 212 , 214 , 216 , 218 , which may be spaced apart, and may radiate in a direction outward from a point on anterior side 202 a , e.g., the center of anterior side 202 a .
- Channels 212 , 214 , 216 , 218 may each define a portion of shell 205 that traverses each of ridges 204 a . 204 b , 204 c .
- Each channel 212 , 214 , 216 , 218 may have a height higher than the valleys that it traverses, and equal to or lower than the ridges that it traverses.
- each of channels 212 , 214 , 216 , 218 may have a height across each of valleys 206 a , 206 b , 206 c , 206 d so as to create a “break” in each valley and connect each of ridges 204 a , 204 b , 204 c , 204 d , 204 e to each adjacent ridge.
- each channel When viewed from the inside of shell 205 , each channel may create a cavity through which fluid may flow from one ridge to another during expansion.
- channels 212 , 214 , 216 , 218 may promote the even flow of fluid between each of ridges 204 a , 204 b , 204 c , 204 d , 204 e when introduced into, or removed from, expander 200 . While FIGS.
- each channel may connect only a subset of the ridges, e.g., ridges 204 a , 204 b , and 204 c ; or ridges 204 c , 204 d , and 204 e ; or ridges 204 a and 204 b (see also FIGS. 3 A- 3 B , discussed below).
- each channel may connect a different subset of the ridges.
- channels 212 , 214 , 216 , 218 may be disposed at equal intervals around a circumference of expander 200 .
- channels 212 , 214 , 216 , 218 may be disposed at 900 intervals relative to one another, as depicted in FIGS. 2 A and 2 B .
- channels 212 , 214 , 216 , 218 may be circumferentially disposed on expander 200 at unequal intervals; for example, channel 212 and channel 214 may be disposed at, e.g., a 45° angle to one another, channel 214 and channel 218 may be disposed at a 135° angle to one another, channel 218 and channel 216 may be disposed at a 45° angle to one another, and channel 216 and channel 212 may be disposed at a 135° angle to one another.
- These intervals are exemplary only as channels 212 , 214 , 216 , 218 may be disposed at generally any angles relative to each other. While four channels are depicted in FIGS.
- channels 212 , 214 , 216 , 218 may be present on expander 200 .
- five, six, seven, or eight or more such channels may radiate in a direction outward on anterior surface 202 a at either equal or unequal intervals.
- the channels may have any configuration and placement that may promote even flow of fluid inside expander 200 between each of ridges 204 a , 204 b , 204 c , 204 d , 204 e , and thus a relatively even expansion of expander 200 , without adversely affecting the size and shape of expander 200 .
- FIGS. 3 A and 3 B illustrate another exemplary tissue expander 300 , comprising a shell 305 having an anterior side 302 a and a posterior side 302 b .
- Expander 300 may have a general configuration similar to expanders 100 and 200 , and may include any features of expanders 100 and/or 200 .
- expander 300 may include ridges 304 a , 304 b , 304 c , 304 d , 304 e , 304 f having shapes and configurations similar to ridges 104 a , 104 b , 104 c of expander 100 , and valleys 306 a .
- 306 b , 306 c , 306 d illustrate another exemplary tissue expander 300 , comprising a shell 305 having an anterior side 302 a and a posterior side 302 b .
- Expander 300 may have a general configuration similar to expanders 100 and 200 , and may include any features of expanders 100 and/or 200 .
- Expander 300 may also include a port connection 310 similar to port connection 110 .
- Bridges such as bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f may be disposed on anterior side 302 a of expander 300 and may each constitute a short channel, e.g., a channel that connects only two ridges, or a channel that connects only a portion of the ridges, such as three adjacent ridges of a total of four or more ridges. Similar to channels 212 , 214 , 216 , 218 of expander 200 , each bridge may be a portion of the shell 305 crossing a valley between two adjacent ridges of the shell.
- bridge 320 a may be a raised portion of shell 305 crossing valley 306 e , between ridges 304 e and 304 f .
- each bridge e.g., bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f
- fluid introduced into expander 300 may travel between ridges 304 a , 304 b , 304 c , 304 d , 304 e , 304 f via, e.g., bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f.
- Bridges may have any suitable shape, such as, e.g., trapezoidal, rectangular, square, or rounded shape, among other possible shapes. Bridges may be the same size and shape as other bridges, or may have a different shape and/or size than other bridges. In some embodiments, bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f may increase in size in proportion with their distance from the center of anterior side 302 a . For example, bridge 320 d may be proportionally larger than bridge 320 f , bridge 320 a may be larger than bridge 320 c , and so forth.
- bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f may have a generally trapezoidal shape, such that the side of each bridge close to the outermost circumference of expander 200 is larger than the side of each bridge closer to the center of anterior side 302 a .
- the acute angles of trapezoidal bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f may range from about 1° to about 440 or from about 5° to about 30°. e.g., a 15°, 20°, 25°, or 30° angle as measured from a center point of anterior side 302 a.
- Two or more bridges may be arranged in a row radiating outward from a point on anterior side 302 a , such as a center point of anterior side 302 a .
- Bridges in a single row may cross alternating valleys to connect adjacent pairs of ridges, e.g., without creating longer channels that extend across multiple valleys.
- bridges in adjacent rows may cross different alternating valleys, for example, the row of bridges 320 a , 320 b , and 320 c may cross valleys 306 e .
- bridges in adjacent rows may cross the same valleys as one another.
- Adjacent rows of bridges may radiate outward on anterior side 302 a at intervals of 180° or less, such as 60°, 90° or 120°.
- each row of bridges radiating outward from a point on anterior side 302 a may be disposed at a 180° angle or a 120° angle relative to another row of bridges having the same configuration.
- tissue expanders may comprise a plurality of bridges arranged in rows that are spaced at regular intervals from adjacent rows, e.g., two rows spaced 180° apart, three rows spaced 120° apart, four rows spaced 90° apart, six rows spaced 60° apart, etc.
- the rows need not be equally spaced apart however.
- rows may comprise bridges at the same or a different radius (relative to the center of the anterior side) than other rows.
- adjacent rows may comprise bridges that are located at the same radial position (see, e.g., FIGS. 2 A- 2 B ) or at different radial positions (see, e.g., FIGS. 3 A- 3 B ).
- bridges e.g., bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f
- bridges may be present in a variety of numbers and configurations.
- four rows of bridges may radiate outward from anterior side 302 a , and the rows may be disposed about anterior side 302 a at equal intervals.
- two, three, five, six, or more rows of bridges may radiate in a direction radially outward on anterior side 302 a , and may be disposed about anterior side 302 a at equal or unequal intervals.
- a first pair of adjacent rows of bridges may be disposed at a 45° angle relative to one another, and a second pair of adjacent rows of bridges may be disposed at a 135° angle relative to one another.
- FIGS. 3 A and 3 B depict rows of three bridges, in some examples the rows may include only two bridges, or four or more bridges. Further, different rows may include the same number of bridges, or different numbers of bridges.
- each row of bridges may include bridges crossing every third valley or every fourth valley, as opposed to every other valley.
- the bridges may not be arranged in rows, but rather may be circumferentially distributed about anterior side 302 a in a staggered formation.
- the bridges may be present in any number, configuration and placement that provides a structure that promotes even flow of fluid inside expander 300 between each of ridges 304 a , 304 b , 304 c , 304 d , 304 e , 304 f , without adversely affecting the size and shape of expander 300 .
- the promotion of even flow of fluid inside expander 300 may promote even expansion of expander 300 upon introduction of fluid inside expander 300 , and may prevent undesirable wrinkling of shell 300 .
- the configuration of ridges, valleys, and channels may promote an even distribution of force.
- the configuration of interconnected channels and ridges may promote an even distribution of force radially outward, e.g., in a spiral.
- the bridges may function similar to a ladder, such that force travels to the proximate bridge and radially outward from an inner ridge to an adjacent outer ridge, then along the outer ridge until it encounters the next bridge, and so on.
- This distribution of force generated on the anterior side 302 a of shell 305 (both inside and outside shell 305 ) may provide for greater control over changes in volume and a more uniform expansion.
- a concentric pattern of interconnected ridges and valleys may allow shell 305 to stretch in order to accommodate changes in volume while avoiding, preventing, or reducing wrinkling of shell 305 .
- FIG. 3 C depicts an exemplary mold 350 , which may be used to prepare an expander, such as expander 300 .
- Mold 350 may have a general shape and size corresponding to a desired shape and size of expander 300 .
- Mold 350 may have an upper surface 352 a and a lower surface 352 b .
- mold 350 may have a surface topography which is the inverse (mirror image) of a desired topography of expander 300 .
- mold 350 may have circumferential grooves 354 a , 354 b , 354 c , 354 d , 354 e , 354 f (corresponding to ridges 304 a , 304 b , 304 c , 304 d , 304 e , 304 f of expander 300 ) separated by hills 356 a , 356 b , 356 c , 356 d , 356 e , 356 f (corresponding to valleys 306 a , 306 b , 306 c . 306 d , 306 e , 306 f of expander 300 ). Additionally, mold 350 may have a plurality of depressions.
- Each depression may thus connect one of grooves 354 a . 354 b , 354 c , 354 d , 354 e , 354 f to an adjacent groove.
- Each depression may correspond to a desired bridge in the surface of an expander, such as one of the bridges in the surface of expander 3 W) (e.g., bridges 320 a , 320 b , 320 c .
- depressions 370 a , 370 b , 370 c , 370 d , 370 e , 370 f may be arranged in any configuration desired for bridges on an expander, e.g., rows, alternating rows, or staggered formations, as have been described with regard to bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f on expander 300 disclosed herein.
- the expander when an expander is cast on mold 350 , removed, and inverted such that the surface formerly in contact with mold 350 forms the outermost surface of the expander, the expander will have the general size and shape of mold 350 , and a surface features that are the mirror image of surface features of mold 350 , including, e.g., ridges defined by grooves in mold 350 , valleys defined by hills on mold 350 , and bridges defined by depressions in mold 350 .
- Mold 350 may comprise a variety of materials, such as metals, metallic alloys, one or more polymers or copolymers, ceramic materials, wood, stone, coral, or any combination thereof.
- Exemplary metallic matenals include, but are not limited to, aluminum and aluminum alloys.
- Exemplary polymer or co-polymer materials include, but are not limited to, polyoxymethylene (acetal copolymer), such as Delrin® acetal homopolymers produced by DuPontTM Any other polymer/copolymer materials suitable for providing a mold on which to cast a tissue expander according to the present disclosure may be used.
- a mirror image of a desired surface texture may be imparted onto the upper surface 352 a and/or the lower surface 352 b of the mold 350 , so as to impart the desired surface texture on an expander.
- Various techniques may be used to texturize the upper surface 352 a and/or lower surface 352 b .
- Various systems and methods for texturizing surfaces of implant molds and mandrels are disclosed in U.S. App. No. 62/334,667, filed on May 11, 2016, and U.S. App. No. 62/410,121, filed on Oct. 19, 2016, which are incorporated by reference herein in their entireties.
- mold 350 may be impacted (e.g., blasted or sandblasted) with an abrasive substance, such as a plurality of abrasive particles.
- abrasive particles may include, but are not limited to, staurolite minerals, quartz, kyanite, titanium minerals and/or their alloys, zircon, heavy metals (e.g., cadmium, selenium, ferrous iron, and/or steel alloys such as tungsten alloys, chromium alloys, magnesium alloys, molybdenum alloys, and vanadium alloys).
- the abrasive particles may be generally non-spherical in shape, e.g., irregular-shaped particles.
- the particles may have a granular, irregular shape.
- the abrasive particles may be generally spherical, ovoid, or otherwise regular in shape.
- the abrasive particles may have generally rounded surfaces.
- the abrasive particles may comprise quartz, and may have generally rounded surfaces clean from extraneous debris, e.g., having less than about 7.0%, less than about 5.0%, less than about 3.0% free silica, or less than about 1.0% free silica.
- the composition and shape of the particles may be selected based at least partially on the composition of the mold 350 , e.g., to provide for a difference in Mohs hardness between the abrasive particles and the mold 350 .
- the abrasive particles may have a Mohs hardness ranging from 5.0 to 8.0, such as from 5.0 to 6.5, from 6.5 to 7.0, or from 7.0 to 8.0.
- the abrasive particles may have a Mohs hardness that is 1-3 values greater than the material(s) of the mold 350 .
- the average diameter of the abrasive particles may range from about 10 ⁇ m to about 500 ⁇ m, such as from about 50 ⁇ m to about 450 ⁇ m, from about 50 ⁇ m to about 250 ⁇ m, from about 50 ⁇ m to about 100 ⁇ m, or from about 75 ⁇ m to about 125 ⁇ m.
- the abrasive particles may comprise quartz with an average diameter ranging from about 50 ⁇ m to about 100 ⁇ m (e.g., a mesh screen size in the range of 50-100 ⁇ m).
- Abrasive particles may be blasted at the mold surface 352 a , 352 b from, for example, a nozzle.
- the distance between the nozzle and the mold surfaces 352 a , 352 b may also be adjusted to affect the surface texture.
- the distance between the nozzle and the mandrel surface may range from about 2 cm to about 75 cm, such as from about 5 cm to about 50 cm, from about 5 cm to about 25 cm, from about 25 cm to about 50 cm, from about 10 cm to about 35 cm, or from about 10 cm to about 25 cm.
- An expander may then be made by, e.g., coating the surface of mold 350 with a material including, e.g., silicone, polyurethane, or a silicone-polyurethane co-polymer.
- the material may be allowed to set by, e.g., curing.
- the material may be inverted, such that the portion of the material previously contacting the surface of mold 350 forms the outermost surface of the expander.
- FIG. 4 depicts an exemplary tissue expander system 400 , including expander 401 and port 470 , which are connected by connector tube 430 .
- Expander 401 comprises a shell 405 having an anterior side 402 a and a posterior side 402 b .
- Expander 401 may have a general size and shape similar to, and may include any of the features of, expanders 100 , 200 , and/or 300 —for example, expander 401 may include ridges 40 a , 406 b , 400 c , 406 d having shapes and configurations similar to ridges 104 a .
- Expander assembly 401 may also include a port connection 410 similar to port connection 110 .
- port connection 410 may include both a base 424 and a protrusion 422 , which may, fluidly connect to, e.g., connector tube 430 .
- Base 424 may be sealed to shell 405 , e.g., by vulcanization or glue, or may be molded as a single piece with shell 405 .
- Bridges e.g., bridges 404 a , 404 b , 404 c , 404 d , 404 e , 404 f , 404 g , 404 h may be circumferentially disposed around anterior side 402 a of expander 401 . Similar to bridges 320 a , 320 b , 320 c , 320 d , 320 e , 320 f of expander 300 , each bridge may be a raised section of the shell 405 crossing a valley between two adjacent ridges in the shell. For example, bridge 404 g may be a raised portion of shell 405 crossing valley 407 b , between ridges 406 a and 406 b .
- the bridges may be arranged in rows radiating in a direction radially outward from a point on anterior side 402 a .
- bridges in a single row may cross alternating valleys.
- Adjacent rows of bridges may radiate outward from anterior side 402 a at intervals of 60°.
- Bridges in adjacent rows may cross different alternating valleys; for example, the row of bridges 404 d and 404 e may cross valleys 407 c and 407 a , respectively, while the adjacent row of bridges 404 f , 404 g , and 404 h may cross valleys 407 d , 407 b , and 407 e , respectively.
- each bridge of expander 401 may have a height across the valley it crosses so as to create a “break” in the valley and connect each of ridges 406 a , 406 b , 406 c , 406 d to an adjacent ridge.
- fluid introduced into expander 401 may travel between the ridges of expander 401 such that any forces exerted on expander 401 are distributed across the surface of expander 401 , promoting even expansion and contraction, and controlling wrinkling of expander 401 .
- bridges on expander 401 may be present in a variety of numbers and configurations.
- six rows of bridges may radiate outward from anterior side 302 a , and the rows may be disposed about anterior side 302 a at equal intervals.
- two, three, four five, seven, eight, or more rows of bridges may radiate outward on anterior side 302 a , at equal or unequal intervals.
- a first pair of adjacent rows of bridges may be disposed at a 45° angle to one another, and a second pair of adjacent rows of bridges may be disposed at a 135° angle to one another.
- each row of bridges may include a bridge crossing every third valley or every fourth valley, as opposed to every other valley.
- the bridges may not be arranged in rows, but rather may be circumferentially distributed around a point on anterior side 402 a in a staggered formation.
- the bridges may be present in any number, configuration and placement that promotes even flow of fluid inside expander 401 between each of ridges 406 a , 406 b , 406 c , and 406 d , without adversely affecting the size and shape of expander 401 .
- the promotion of even flow of fluid inside expander 401 may promote uniform expansion of expander 401 upon introduction of more fluid inside expander 401 .
- Port 470 may include, as pictured in view 480 , a base 482 , a ring 484 , and a cap 486 , each of which may be made using one or more biocompatible materials, such as plastic (e.g., polyoxymethylene), silicone, or metal (e.g., titanium). Port 470 may be fluidly connected to expander 401 and may be configured to receive fluid for delivery into, or removal from, expander 401 .
- Cap 486 may include an insertion point through which fluid may be received into port 470 , and an exit hole 488 through which fluid may be fed to expander 401 .
- Cap 486 may be made of, e.g., a self-sealing material that may be penetrated by a fluid delivery device, such as a needle that may deliver fluid.
- Ring 484 may be located below cap 486 and may surround the insertion point in cap 486 .
- Ring 484 may include, e.g., a material that may resist penetration by a fluid delivery device, such as a metal or plastic material.
- Ring 484 may have an aperture 485 through which fluid introduced via cap 486 may travel to exit hole 488 .
- Base 482 may also include a material that may resist penetration by a fluid delivery device, such as a metal or plastic material.
- Base 482 may be affixed to ring 484 and/or cap 486 so as to create an enclosure into which fluid may be delivered through cap 486 , and out of which fluid may exit through exit hole 488 .
- Port 470 may be fluidly connected to expander 401 via, for example, connector tube 430 .
- Connector tube 430 may include a lumen 462 (depicted in view 460 ) suitable for carrying fluid from port 470 to port connection 410 .
- Connector tube 430 may be made of one or more biocompatible materials suitable for implantation in a patient's body.
- connector tube 430 may include any material suitable for inclusion in expander 401 .
- connector tube 430 may have an inner or outer surface having a texture, such as any texture suitable for an inner or outer surface of expander 401 .
- connector tube 430 may be flexible, such that it may be bent into multiple configurations.
- connector tube 430 may be kink resistant, such that it does not collapse and limit or prevent flow of fluids inside.
- Connector tube 430 may be any suitable length allowing for a desired placement of expander 401 and port 470 .
- Connector tube 430 may be fluidly connected on one end to port 470 via, for example, exit hole 488 , and may be fluidly connected on the other end to an opening into an interior of expander 401 , such as port connection 410 .
- expander system 400 may include one or more valves (not pictured) which may restrict the flow of fluid out of or into expander 401 .
- port 470 may be connected directly to expander 401 without connector tube 430 .
- port 470 may be integrated into shell 405 of expander 401 .
- a top of port cap 486 may be approximately flush with a portion of anterior side 402 a or posterior side 402 b of expander 401 .
- port 470 may be affixed to shell 405 in an opening in anterior side 402 a or posterior side 402 b of expander 401 .
- port 470 may include one or more features configured to facilitate locating port 470 in cases where port 470 may not be visible, such as when port 470 is implanted internally in a patient.
- port 470 may include an electromagnetic coil within ring 484 which may be centered around a needle insertion point in cap 486 , and which may be detectable using an electromagnetic signal detector, such as a radiofrequency reader. Detection of the electromagnetic coil may facilitate location of the needle insertion point.
- port 470 may include one or more features configured to prevent over insertion of a needle through cap 486 , such as a reinforced base 482 .
- Various systems and methods for assisting in locating ports and preventing needle over insertion into ports are disclosed in U.S. application Ser. No. 15/427,599, filed on Feb. 8, 2017, which is incorporated by reference herein in its entirety.
- Expanders according to the present disclosure may have a variety of shapes and sizes suitable for their use.
- expanders 100 , 200 , 300 , and 401 are depicted as having generally circular shapes when viewed from the anterior side (top view) or posterior side (bottom view) (including, for example, a circular posterior side)
- expanders according to the present disclosure may have, e.g., oval, teardrop, or other shapes for creating a suitable tissue pocket to receive a similarly-shaped implant.
- the “apex” of expanders according to the present disclosure in their expanded forms (having a generally domed or hemispherical shape as viewed from the side) may be centered or may be off-center.
- the apex refers to the point on either the anterior or posterior side of an expander that is farthest from the opposite (posterior or anterior, respectively) side of the expander in its expanded form, and may be centered on the anterior or posterior side, or alternatively be located at an off-center point.
- the apex may be positioned between the center point and the outer edge of the anterior surface, so as to more precisely mimic the shape of the implant to be inserted into the pocket formed by the expander and the desired shape of tissue following insertion of the implant.
- a tissue expander for use in the breast may have a tear-drop shape and/or an apex that is off-center on the anterior side of the expander, so as to more realistically simulate the shape of a human breast.
- the shell may include a series of ridges and valleys centered at the apex (e.g., concentric or otherwise rounded, such as oval or tear drop in shape), similar to those shown in FIGS. 1 A- 1 B, 2 A- 2 B, and 3 A- 3 B .
- Tissue expanders according to the present disclosure may be made in a variety of ways.
- FIG. 5 depicts an exemplary method by which an expander according to the present disclosure may be manufactured.
- a mold may be coated with a liquid dispersion of a biocompatible material.
- the material coating the mold may be allowed to set or cure (e.g., by application of heat) to form a flexible expander shell.
- the expander shell may be removed from the mold.
- the expander shell may be inverted, or turned inside out.
- the expander may be sealed.
- a mold may be coated in a liquid dispersion of a material.
- the mold may have an inverse of a shape and topography of a desired expander.
- mold 350 may be used to make an expander such as expander 300 .
- the mold may have the same shape and topography as a desired expander.
- the mold may be a hollow mold, the inside of which may be coated in a liquid dispersion (in which case the shell may not be inverted as discussed below).
- the mold may be coated in a dispersion of any material suitable for use in the shell of the desired expander, such as a silicone, a polyurethane, a silicone or polyurethane copolymer, or a silicone and polyurethane copolymer.
- the mold may be coated in a dispersion multiple times, so as to create a desired shell thickness.
- the mold may be coated in multiple different dispersions, such as dispersions of both clear and colored silicone or other material.
- the mold (such as mold 350 ) may be coated in a liquid dispersion using a dip-molding process. In other embodiments, a rotational molding process may be used.
- the material coating the mold may be allowed to set or cure into an expander shell.
- the material and mold may be cured together at a suitable temperature.
- a mold coated with a silicone material may be cured at a temperature ranging from about 100° C. to about 200° C., such as from about 125° C. to about 175° C., or from about 125° C. to about 150° C.
- the curing temperature may range from about 125° C. to about 127° C., e.g., about 125° C., about 126° C., or about 127° C.
- the curing temperature may be about 150° C.
- the expander shell may be removed from the mold.
- an aperture may exist or be created in the shell so as to remove the shell from the mold.
- the expander shell may then be inverted, or turned inside out.
- the surface of the shell formerly in contact with the mold e.g., mold 350
- the cured shell may be removed from a mold, such as a rotational mold, and may not be turned inside out.
- the expander shell may be sealed.
- an aperture existed or was created so as to remove the expander shell from the mold, such an aperture may be sealed using, e.g., vulcanization, glue, or other methods.
- the expander shell may be sealed to a port or a port connector, through which fluid may be introduced into the expander.
- the port or port connector may be coupled to, or incorporated into, the aperture of the shell used to remove the mold, or another aperture or opening created so as to accommodate the port or port connector.
- a connector tube may be coupled to a port connector that is coupled to or otherwise incorporated into an aperture of the shell, and may be affixed using, e.g., vulcanization or glue.
- a port or port connector connector may be removably coupled to a connector tube.
- Expanders according to the present disclosure may be used in a variety of different procedures.
- expanders according to the present disclosure may be useful in tissue reconstruction surgery and/or elective surgery for esthetic purposes, including minimally-invasive surgery.
- the expanders of the present disclosure may include a flexible, elastic shell that allows the expanders to be folded or rolled prior to insertion into patient tissue, thus allowing them to be inserted through a relatively small incision.
- the elasticity and/or surface features of the expanders disclosed herein may allow the expanders to roll and unroll, fold and unfold, and/or expand and contract in a controlled, predictable fashion, thus allowing for control and predictability of the expanders' behavior upon implantation in a patient.
- topographies of expanders disclosed herein may provide a structure and/or shape to which the expanders may return more easily, thus helping to avoid unwanted wrinkling or creasing of the expanders.
- the expanders may be inserted into a patient without fluid (e.g., to be filled after insertion) or partially filled with fluid (e.g., to be additionally filled after insertion).
- expanders according to the present disclosure may expand uniformly to several different sizes. This is depicted with regard to expander 100 in FIGS. 6 A- 6 C .
- FIG. 6 A depicts, for example, expander 100 in a contracted form.
- expander 100 may be inserted into a patient while in the contracted form.
- FIG. 6 B depicts, for example, expander 100 in a partially expanded form, such as when some fluid has been introduced into expander 100 , e.g., following insertion into the patient.
- FIG. 6 C depicts, for example, expander 100 in more fully expanded form, when additional fluid has been introduced into expander 100 , e.g., after the expander 100 has been implanted for a period of time to allow for gradual tissue expansion.
- any suitable fluid may be used, including, but not limited to, water, saline solution (or other biocompatible solution), silicone gel (or other biocompatible gel), or air (or other biocompatible gas, e.g., nitrogen).
- Tissue expansion may occur over the span of weeks to months, e.g., from about 4 weeks to about 24 weeks, or from about 6 weeks to about 8 weeks. e.g., about 4, 6, 8, 10, 12, 14, 16, 20, 22, or 24 weeks or more.
- the fluid may be at least partially or completely removed from expander 100 , e.g., via port connector 110 , prior to removal from the patient once sufficient tissue expansion has been achieved.
Abstract
Tissue expanders and methods of their manufacture and use are disclosed herein. A tissue expander shell according to the present disclosure may include a shape and topography that facilitates uniform or substantially uniform expansion and contraction of the tissue expander. In at least one example, the shell may include a series of topographical features, such as ridges, grooves, channels, valleys, canals, protrusions, pleats, creases, or folds. In some embodiments, these features may have a curved or wavy cross sectional profile. For example, the shell may include a series of concentric curved ridges.
Description
- This application claims priority to U.S. Provisional Application No. 62/414,269, filed on Oct. 28, 2016, which is incorporated by reference herein in its entirety.
- The present disclosure relates generally to implantable medical devices such as tissue expanders and methods of use thereof.
- Patients have implants for a variety of medical and/or esthetic reasons. Implants may be useful to correct natural asymmetries in body shape, to adjust the size and/or shape of certain features, or for post-operative reconstruction. For example, a breast prosthesis may be used to augment or decrease the size of the breast, or to correct asymmetry in breast shape or volume following surgery, such as a mastectomy or partial mastectomy to remove cancerous breast tissue. Prior to implantation of a prosthesis, a sizer or tissue expander may be inserted temporarily to help to create or maintain the space necessary for the more permanent prosthesis. Keeping living tissues under tension by means of a tissue expander can promote formation of new tissue. As the tissue expander is enlarged over time, the surrounding tissues can expand to the point where the prosthesis may be implanted. Tissue expanders also may be used to spur the growth of new skin and subcutaneous tissue in other parts of the body.
- The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various examples and, together with the description, serve to explain the principles of the present disclosure. Any features of an embodiment or example described herein (e.g., device, method, etc.) may be combined with any other embodiment or example, and such combinations are encompassed by the present disclosure.
-
FIGS. 1A and 1B show an exemplary device, according to some aspects of the present disclosure. -
FIGS. 2A and 2B show another exemplary device, according to some aspects of the present disclosure. -
FIGS. 3A and 3B show a further exemplary device, andFIG. 3C shows a mold for the device, according to some aspects of the present disclosure. -
FIG. 4 shows an exemplary system, according to some aspects of the present disclosure. -
FIG. 5 is a flow diagram showing an exemplary method by which an expander may be made, according to the present disclosure. -
FIGS. 6A, 6B, and 6C show three states of expansion of the exemplary device ofFIGS. 1A and 1B . - Aspects of the present disclosure include a tissue expander having a flexible shell. The shell defines a cavity therein, and includes a plurality of ridges that curve along a surface of the shell about an axis, each ridge having a width and a length longer than the width. In some embodiments, the shell includes an anterior side and a posterior side, the anterior side having an apex, wherein each ridge of the plurality of ridges is disposed circumferentially around the apex. In further embodiments, the plurality of ridges includes a first annular ridge and a second annular ridge concentric with the first annular ridge.
- In yet further embodiments, the plurality of curved ridges includes at least one channel connecting two adjacent ridges. In some such embodiments, the at least one channel includes two channels each extending radially outward, the two channels being disposed at least 45° apart about a circumference of the shell.
- In still further embodiments, the plurality of ridges includes a first ridge and a second ridge, the shell further including a plurality of channels connecting the first ridge and the second ridge, wherein the plurality of channels are circumferentially disposed at intervals around an apex of the shell. In further embodiments, the plurality of ridges includes at least three ridges each separated from an adjacent ridge by a valley. In some such embodiments, the at least three ridges are disposed circumferentially around an apex of the shell, and the plurality of channels comprises, a first channel connecting the first ridge to the second ridge and traversing the valley between them; and a second channel connecting the second ridge to the third ridge and traversing the valley between them. In some such embodiments, the first channel, the second channel, and the apex are not co-linear. In some such embodiments, the first channel does not connect to the third ridge.
- In some embodiments, the shell of the tissue expander is flexible and comprises silicone, polyurethane, or a copolymer thereof. In some embodiments, the shell has a uniform thickness ranging from about 0.3 mm to about 0.6 mm. In further embodiments, at least one of the anterior side or the posterior side of the shell is textured. In further embodiments, the tissue expander includes a port connector coupled to the shell.
- Aspects of the present disclosure also include a tissue expander including a flexible shell defining a cavity therein. The shell includes a plurality of ridges, each ridge curving along a surface of the shell around an apex, and each ridge having a width and a length longer than the width. The shell also includes a channel connecting at least two of the ridges, and the shell has a uniform thickness.
- In some such embodiments, the channel is a first channel, and the shell further includes a second channel connecting at least two of the ridges. In further embodiments, the plurality of ridges includes at least three concentric ridges. In yet further embodiments, the shell includes a plurality of channels, each channel connecting only two adjacent ridges of the plurality of ridges. In some embodiments, the tissue expander includes a port connector integrated into a portion of the shell.
- Aspects of the present disclosure also include a tissue expander having a flexible shell defining a cavity therein, where the shell includes a plurality of parallel ridges that curve along a surface of the shell, each ridge having a width and a length longer than the width, and a plurality of channels extending radially outward, each channel connecting at least two adjacent ridges of the plurality of ridges.
- In some such embodiments, the plurality of channels are disposed in a staggered configuration. In further embodiments, the tissue expander has a circular, oval, rectangular, spherical, crescent, or teardrop cross-sectional shape. In yet further embodiments, the plurality of parallel ridges comprises concentric ridges on an anterior surface of the shell, and the shell is configured to distribute force applied to the anterior surface radially outward. In further embodiments, the plurality of channels comprises at least three channels arranged into rows and spaced at regular intervals.
- Aspects of the present disclosure also include a method of making a tissue expander. The method includes coating a mold with a liquid dispersion to form a shell, the mold including a plurality of circumferential grooves, curing the shell, and removing the shell from the mold, wherein the shell includes a plurality of ridges corresponding to the plurality of circumferential grooves of the mold.
- In some embodiments, the liquid dispersion comprises silicone, polyurethane, or a mixture thereof. In further embodiments, the method further includes inverting the shell such that the plurality of ridges are disposed on an outermost surface of the shell. In further embodiments, the shell has a uniform thickness ranging from about 0.3 mm to about 0.6 mm.
- Aspects of the present disclosure also include a tissue expander mold. The tissue expander mold includes: a body including a plurality of circumferential grooves, each groove curving along a surface of the body about a center axis of the body, each groove having a width and a length longer than the width, and a depression connecting at least two of the grooves.
- In some embodiments, the plurality of grooves includes at least three grooves that curve parallel to each other around an apex of the body. In further embodiments, the surface of the body is texturized.
- Particular aspects of the present disclosure are described in greater detail below. The terms and definitions provided herein control, if in conflict with terms and/or definitions incorporated by reference.
- As used herein, the terms “comprises,” “comprising.” or any other variation thereof are intended to cover a non-exclusive inclusion, such that a process, method, composition, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such process, method, composition, article, or apparatus. The term “exemplary” is used in the sense of “example” rather than “ideal.”
- As used herein, the singular forms “a,” “an,” and “the” include plural reference unless the context dictates otherwise. The terms “approximately” and “about” refer to being nearly the same as a referenced number or value. As used herein, the terms “approximately” and “about” should be understood to encompass±10% of a specified amount or value.
- As used herein, the term “posterior” refers to the back of a patient, and the term “anterior” refers to front of a patient. Thus, the posterior side of a breast implant is the side of the implant facing the chest wall, while the anterior side is the opposite side closest to the skin. Similarly, the posterior side of a gluteal or buttock implant is the side closest to the skin, and the anterior side is the opposite side facing the pelvis.
- Tissue expanders may be used to stretch or promote growth of tissue in a patient in preparation for an implant. For example, a surgeon may place a tissue expander in a mastectomy patient as part of reconstructive repair of breast tissue. Tissue expanders generally include a fill port to allow for introduction of a liquid or gel (e.g., saline solution or other biocompatible liquid or gel) over time. The prosthesis is typically implanted into the breast cavity in an empty or only partially filled state. The implant may then be inflated to its desired size via a valve or fill port. Gradual inflation at pre-determined intervals may cause the skin and subcutaneous tissues overlying the expander to expand in response to the pressure exerted upon the tissue as the liquid or gel is introduced into the tissue expander. The skin and subcutaneous tissue may expand to the point where further medical procedures can be performed, such as the permanent implantation of a prosthesis, plastic and reconstructive surgery, or for use of the skin and subcutaneous tissue for use in some other part of the body.
- Volume adjustment may be beneficial, e.g., to make a later adjustment of size without having to replace the prosthesis with one of a different size, which would require a subsequent surgical procedure.
- Tissue expansion may occur over the span of weeks to months, e.g., from about 4 weeks to about 24 weeks, or from about 6 weeks to about 8 weeks, e.g., about 4, 6, 8, 10, 12, 14, or 16 weeks or more.
- Tissue expanders (sometimes known as “sizers”) according to the present disclosure may comprise a flexible shell that allows for their expansion and contraction, e.g., upon introduction and removal, respectively, of a fluid in a cavity defined by the shell. In some aspects of the present disclosure, a shell of a tissue expander may have a shape and topography that facilitates uniform or substantially uniform expansion of the tissue expander. For example, the topography of a tissue expander shell may promote an even distribution of force of fluid within the tissue expander against the inner surface of the shell as the fluid is introduced into the shell. The topography of the shell may also promote an even distribution of force of the outer surface of the tissue expander against surrounding tissue, even as the device expands and changes sizes. Additionally or alternatively, the topography of the shell may promote retention of the shell's shape, with or without fluid inside, by discouraging wrinkling or unwanted folding of the shell. Tissue expanders may be implanted in a patient for a number of weeks or months, e.g., from about 4 weeks to about 8 months, or from about 6 weeks to about 6 months, e.g., about 4, 6, 8, 10, 12, 14, 16, 20, or 24 weeks or more.
- In some embodiments of the present disclosure, the shell may have an approximately uniform thickness. In alternative embodiments, the shell may have a thickness that is greater on one side than the other (e.g., a posterior side of the shell may be thicker than an anterior side of the shell), or within different areas or regions of the shell. The thickness of the shell may range from about 0.1 mm to about 1.2 mm, such as from about 0.2 mm to about 0.8 mm, from about 0.3 mm to about 1.1 mm, from about 0.3 mm to about 0.4 mm, or from about 0.4 mm to about 0.6 mm. In some examples, the thickness of the shell may range from about 0.33 mm to 1.02 mm, e.g., a thickness of about 0.35 mm, about 0.4 mm, about 0.45 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, or about 1.0 mm. For example, the shell may have a uniform thickness ranging from about 0.4 mm to about 0.6 mm.
- In at least one example, the shell may include a series of features, such as grooves, canals, protrusions (e.g., rounded or folded ridges), pleats, creases, or folds, that allow the device to expand uniformly (e.g., similar to a bellows), promote even distribution of force of the device against surrounding tissue in which the device is implanted, and/or promote retention of the device's shape when both expanded and contracted. Thus, for example, the configuration of the shell may help to control the way forces are applied to the device and/or to accommodate changes in volume while minimizing or avoiding wrinkling, bending, or twisting of the shell. In some embodiments, these features may have a curved or wavy cross sectional profile. For example, the shell may include a series of concentric curved pleats, having an approximately sinusoidal or wavy cross-sectional profile.
-
FIGS. 1A-1B, 2A-2B, 3A-3B, and 4 , discussed below, illustrate various examples of tissue expanders having features that provide for such expansion characteristics. While aspects of the present disclosure may be described in the context of a given type of tissue expander, such as, for example, an expander for placement in breast tissue, embodiments of the present disclosure may be, and/or may be applied to, a variety of medical procedures. Non-limiting examples include expanders prior to placement of other body contour implants such as gluteal, calf, etc., as well as to promote growth of skin or other tissue for various reconstructive or transplantation surgeries. For example, the tissue expanders herein may be used for skin regeneration. e.g., in order to replace damaged tissue, including scarred or burned tissue. - The shell may comprise a biocompatible material or combination of biocompatible materials that allow the shell to flex. The material(s) may be elastic, such that the shell may retain its integrity after expansion and/or repeated cycles of expansion and contraction. Exemplary materials suitable for the shell include, but are not limited to, elastic polymers and copolymers, such as, e.g., silicone, polyurethane, polyurethane blends, silicone/polyurethane polymers and copolymers, polyethylene terephthalate (PET), polyether block amide (PEBA, e.g., Pebax®), and polyanude 12 (e.g., Grilamid® and Vestamid®). These materials may be formed into layers, for example, and may have varying degrees of elasticity or hardness. For example, in some aspects of the present disclosure, the shell or shell material may have an elongation value between about 350% and about 900%, such as between about 400% and about 850%, between about 450% and about 850%, between about 450% and about 750%, between about 450% and about 650%, or between about 500% and about 600%, e.g., about 350%, about 400%, about 450%, about 500%, about 550%, about 600%, about 650%, about 700%, about 750%, or about 800% Additionally or alternatively, the shell or shell material may have a hardness between about 15 and about 95 (Shore A durometer), such as between about 25 and about 35, between about 25 and about 50, between about 30 and about 60, between about 40 and about 70, between about 50 and about 80, or between about 60 and about 90, e.g., about 20, about 25, about 30, about 35, about 40, about 45, about 50, about 55, about 60, about 65, about 70, about 75, about 80, about 85, or about 90 (Shore A durometer). Any suitable fluid may be introduced and/or removed from the tissue expanders herein, such as, e.g., water, saline solution (or other biocompatible solution), silicone gel (or other biocompatible gel), or air (or other biocompatible gas, e.g., nitrogen).
- In some examples, the outer and/or inner surface of the shell may be texturized. For example, the outer and/or inner surface of the shell may include any combination of surface features (e.g., roughness, skewness, kurtosis, peak height, valley depth, and/or contact point density values) that provide a surface texture or multiple surface textures as disclosed in U.S. Provisional Application No. 62/334,667 filed on May 11, 2016, and/or U.S. Provisional Application No. 62/410,121 filed on Oct. 19, 2016, each of which is incorporated by reference herein in its entirety. In at least one example, all or a portion of the outer surface of the tissue expander may have an average roughness (Sa) of 4.0 μm±2 μm, a skewness value of 0.6±0.4, kurtosis value of 3.5±0.5, a maximum peak height of 14 μm±2 μm, a maximum valley depth of 12 μm±2 μm, and a contact point density ranging from 20,000 peaks/cm2 to 60,000 peaks/cm2, such as from 45,000 peaks/cm2 to 55,000 peaks/cm2. Such texturization may be provided by use of a texturized mold, as is further described elsewhere herein.
-
FIGS. 1A and 1B illustrate anexemplary tissue expander 100 comprising ashell 105 having ananterior side 102 a and aposterior side 102 b.FIG. 1A depicts a top-down view ofexpander 100, andFIG. 1B depicts a side view ofexpander 100.Expander 100 may be useful for preparing a pocket, e.g., a subglandular pocket or a submuscular pocket, in the chest tissue of a patient prior to insertion of an implant.Expander 100 may include a series of topographical features such asridges valleys anterior side 102 a and/or theposterior side 102 b, defining the surface ofexpander 100. Theexpander 100 may also include aport connection 110, which may fluidly connect the interior ofexpander 100 to a port, such asport 470 depicted inFIG. 4 (further discussed below). Thus, for example,shell 105 may define an expandable cavity or bladder, whereinport 470 allows for introduction and/or removal of a fluid that provides for the expansion or contraction ofexpander 100. -
Expander 100 may have a size and shape suitable for preparing a pocket or cavity in the chest tissue of a patient for receiving a breast implant.Expander 100 may have, for example, a generally circular cross-sectional area, including a circularposterior side 102 b, suitable for contacting the wall of a patient's chest cavity. The cross-sectional area may decrease fromposterior side 102 b toanterior side 102 a, such that, upon expansion,expander 100 may have an arched or dome-like shape, similar to the shape of a breast or breast implant.Expander 100 may be expandable in the anterior-posterior direction (i.e., such thatanterior side 102 a moves away fromposterior side 102 b) upon introduction of fluid intoexpander 100. Likewise,expander 100 may be contractible in the anterior-posterior direction (i.e., such thatanterior side 102 a moves away fromposterior side 102 b) upon removal of fluid from withinexpander 100. -
Ridges valleys 106 a. 106 b. 106 c, 106 d may be arranged so as to promote retention ofexpander 100's shape, and/or uniform expansion and contraction ofexpander 100. For example, as depicted inFIGS. 1A and 1B ,ridges 104 a. 104 b, 104 c may be circular or otherwise rounded (e.g., oval) ridges arranged in a concentric pattern radiating outward from a point (e.g., a center point) onanterior side 102 a, and may be disposed in an alternating arrangement with circular or otherwise rounded (e.g., oval)valleys shell 105. For example, the centermost portion ofanterior side 102 a may have a curved, convex shape that transitions radially outward into avalley 106 a, followed by aridge 104 a, and so on. In some embodiments,ridges valleys expander 100, upon expansion, assumes a domed shape where the center ofanterior side 102 a is at an apex of the dome. Each ridge and valley may follow a continuous, circular path about the center ofanterior side 102 a, e.g., as shown inFIGS. 1A and 1B , each ridge or valley having a uniform height or depth. In other examples, one or more of the ridges and/or valleys may not be continuous about the surface of the shell. e.g., having a variable height or depth. For example, the expander may include channels and/or bridges between adjacent ridges or valleys (see. e.g.,FIGS. 2A-2B, 3A-3B, and 4 , discussed below). - In some embodiments,
expander 100 may include more or fewer ridges and valleys than are depicted inFIGS. 1A and 1B . For example, in some embodiments,expander 100 may include two, three, five, six, seven, or more ridges and/or valleys. In some examples, the configuration of ridges and valleys may allow for each ridge to expand and/or collapse independently of the other ridges. It will be apparent to one of ordinary skill in the art that any suitable number of ridges and/or valleys may be included so as to promote uniform expansion and contraction ofexpander 100, promote uniform exertion of outward force byexpander 100 against surrounding tissue, and/or promote retention of the shape ofexpander 100. In some embodiments, a suitable number of ridges and/or valleys may be included to provide structure toexpander 100, such that when compressive force is applied to and/or fluid is removed fromexpander 100,expander 100 collapses, if at all, along the lines of the ridges and valleys, thus controlling, preventing, or reducing wrinkles inexpander 100. Further, for example, the ridges may allowshell 105 to stretch in a manner so as to accommodate changes in volume without wrinkling ofshell 105. -
Port connection 110 may be situated in an opening inshell 105, and may be configured to fluidly connect to, e.g., a lumen or a port, through which fluid may be introduced into and/or removed fromexpander 100.Port connection 110 may be secured in the opening inshell 105. In some embodiments,port connection 110 may be sealed to shell 105, by, e.g., vulcanization or glue, adhered using, e.g., heat, such that fluid may not enter or exitexpander 100 except for throughport connection 110. In some examples,port connection 110 may comprise an integral portion ofshell 105, e.g., whereinport connection 110 may be molded together withshell 105 to form a one piece component ofexpander 100, such that fluid enters and exitsexpander 100 only throughport connection 110. -
FIGS. 2A and 2B illustrate anexemplary tissue expander 200 comprising ashell 205 having ananterior side 202 a and aposterior side 202 b.Expander 200 may be similar toexpander 100 and include any of the features ofexpander 100—for example,expander 200 may have a general size and shape similar to that ofexpander 100.Expander 200 may includeridges ridges valleys valleys Expander 200 may also include aport connection 210 similar toport connection 110. - As mentioned above, the expanders herein may include features that connect ridges and/or valleys on the anterior side and/or posterior side of the shell. For example,
expander 200 includeschannels anterior side 202 a, e.g., the center ofanterior side 202 a.Channels shell 205 that traverses each ofridges 204 a. 204 b, 204 c. 204 d, 204 e, andvalleys channel channels valleys ridges shell 205, each channel may create a cavity through which fluid may flow from one ridge to another during expansion. Thus, for example, when force (e.g., compressive force) is applied to the center ofanterior side 202 a ofexpander 200, the configuration of interconnected channels and ridges may promote an even distribution of force radially outward, towards a circumference ofexpander 200 and towardposterior side 202 b. In this manner,channels ridges expander 200. WhileFIGS. 2A and 2B showchannels ridges ridges ridges 204 c, 204 d, and 204 e; orridges FIGS. 3A-3B , discussed below). Moreover, each channel may connect a different subset of the ridges. - In some embodiments,
channels expander 200. For example,channels FIGS. 2A and 2B . In further embodiments,channels expander 200 at unequal intervals; for example,channel 212 andchannel 214 may be disposed at, e.g., a 45° angle to one another,channel 214 andchannel 218 may be disposed at a 135° angle to one another,channel 218 andchannel 216 may be disposed at a 45° angle to one another, andchannel 216 andchannel 212 may be disposed at a 135° angle to one another. These intervals are exemplary only aschannels FIGS. 2A and 2B , more or fewer than four channels may be present onexpander 200. For example, in some embodiments, only one, two, or three ofchannels expander 200. In further embodiments, five, six, seven, or eight or more such channels may radiate in a direction outward onanterior surface 202 a at either equal or unequal intervals. One of skill in the art will recognize that the channels may have any configuration and placement that may promote even flow of fluid insideexpander 200 between each ofridges expander 200, without adversely affecting the size and shape ofexpander 200. -
FIGS. 3A and 3B illustrate anotherexemplary tissue expander 300, comprising ashell 305 having ananterior side 302 a and aposterior side 302 b.Expander 300 may have a general configuration similar toexpanders expanders 100 and/or 200. For example,expander 300 may includeridges ridges expander 100, and valleys 306 a. 306 b, 306 c, 306 d. 306 e, 306 f having shapes and configurations similar tovalleys expander 100.Expander 300 may also include aport connection 310 similar toport connection 110. - Bridges, such as
bridges anterior side 302 a ofexpander 300 and may each constitute a short channel, e.g., a channel that connects only two ridges, or a channel that connects only a portion of the ridges, such as three adjacent ridges of a total of four or more ridges. Similar tochannels expander 200, each bridge may be a portion of theshell 305 crossing a valley between two adjacent ridges of the shell. For example, bridge 320 a may be a raised portion ofshell 305 crossing valley 306 e, betweenridges 304 e and 304 f. As withchannels ridges expander 300 may travel betweenridges - Bridges may have any suitable shape, such as, e.g., trapezoidal, rectangular, square, or rounded shape, among other possible shapes. Bridges may be the same size and shape as other bridges, or may have a different shape and/or size than other bridges. In some embodiments,
bridges anterior side 302 a. For example,bridge 320 d may be proportionally larger than bridge 320 f, bridge 320 a may be larger thanbridge 320 c, and so forth. In some embodiments,bridges expander 200 is larger than the side of each bridge closer to the center ofanterior side 302 a. In some embodiments, the acute angles oftrapezoidal bridges anterior side 302 a. - Two or more bridges may be arranged in a row radiating outward from a point on
anterior side 302 a, such as a center point ofanterior side 302 a. Bridges in a single row may cross alternating valleys to connect adjacent pairs of ridges, e.g., without creating longer channels that extend across multiple valleys. In some embodiments, bridges in adjacent rows may cross different alternating valleys, for example, the row ofbridges bridges valleys anterior side 302 a at intervals of 180° or less, such as 60°, 90° or 120°. In some embodiments, each row of bridges radiating outward from a point onanterior side 302 a may be disposed at a 180° angle or a 120° angle relative to another row of bridges having the same configuration. - Thus, for example, tissue expanders according to the present disclosure may comprise a plurality of bridges arranged in rows that are spaced at regular intervals from adjacent rows, e.g., two rows spaced 180° apart, three rows spaced 120° apart, four rows spaced 90° apart, six rows spaced 60° apart, etc. The rows need not be equally spaced apart however. Further, rows may comprise bridges at the same or a different radius (relative to the center of the anterior side) than other rows. For example, adjacent rows may comprise bridges that are located at the same radial position (see, e.g.,
FIGS. 2A-2B ) or at different radial positions (see, e.g.,FIGS. 3A-3B ). - As with
channels expander 200, bridges (e.g., bridges 320 a, 320 b, 320 c, 320 d, 320 e, 320 f) ofexpander 300 may be present in a variety of numbers and configurations. For example, as depicted inFIGS. 3A and 3B , four rows of bridges may radiate outward fromanterior side 302 a, and the rows may be disposed aboutanterior side 302 a at equal intervals. In further embodiments, two, three, five, six, or more rows of bridges may radiate in a direction radially outward onanterior side 302 a, and may be disposed aboutanterior side 302 a at equal or unequal intervals. For example, in one alternative configuration, a first pair of adjacent rows of bridges may be disposed at a 45° angle relative to one another, and a second pair of adjacent rows of bridges may be disposed at a 135° angle relative to one another. WhileFIGS. 3A and 3B depict rows of three bridges, in some examples the rows may include only two bridges, or four or more bridges. Further, different rows may include the same number of bridges, or different numbers of bridges. - In yet further embodiments, each row of bridges may include bridges crossing every third valley or every fourth valley, as opposed to every other valley. In yet further embodiments, the bridges may not be arranged in rows, but rather may be circumferentially distributed about
anterior side 302 a in a staggered formation. One of skill in the art will recognize that the bridges may be present in any number, configuration and placement that provides a structure that promotes even flow of fluid insideexpander 300 between each ofridges expander 300. One of skill in the art will further understand that the promotion of even flow of fluid insideexpander 300 may promote even expansion ofexpander 300 upon introduction of fluid insideexpander 300, and may prevent undesirable wrinkling ofshell 300. - Similar to expander 200 above, the configuration of ridges, valleys, and channels may promote an even distribution of force. For example, when force is applied to the center of
anterior side 302 a, the configuration of interconnected channels and ridges may promote an even distribution of force radially outward, e.g., in a spiral. The bridges may function similar to a ladder, such that force travels to the proximate bridge and radially outward from an inner ridge to an adjacent outer ridge, then along the outer ridge until it encounters the next bridge, and so on. This distribution of force generated on theanterior side 302 a of shell 305 (both inside and outside shell 305) may provide for greater control over changes in volume and a more uniform expansion. Thus, for example, a concentric pattern of interconnected ridges and valleys may allowshell 305 to stretch in order to accommodate changes in volume while avoiding, preventing, or reducing wrinkling ofshell 305. -
FIG. 3C depicts anexemplary mold 350, which may be used to prepare an expander, such asexpander 300.Mold 350 may have a general shape and size corresponding to a desired shape and size ofexpander 300.Mold 350 may have an upper surface 352 a and a lower surface 352 b. Additionally,mold 350 may have a surface topography which is the inverse (mirror image) of a desired topography ofexpander 300. For example,mold 350 may havecircumferential grooves ridges hills valleys 306 a, 306 b, 306 c. 306 d, 306 e, 306 f of expander 300). Additionally,mold 350 may have a plurality of depressions. e.g.,depressions f crossing hills grooves 354 a. 354 b, 354 c, 354 d, 354 e, 354 f to an adjacent groove. Each depression may correspond to a desired bridge in the surface of an expander, such as one of the bridges in the surface of expander 3W) (e.g., bridges 320 a, 320 b, 320 c. 320 d. 320 e. 320 f). As such,depressions bridges expander 300 disclosed herein. As such, when an expander is cast onmold 350, removed, and inverted such that the surface formerly in contact withmold 350 forms the outermost surface of the expander, the expander will have the general size and shape ofmold 350, and a surface features that are the mirror image of surface features ofmold 350, including, e.g., ridges defined by grooves inmold 350, valleys defined by hills onmold 350, and bridges defined by depressions inmold 350. -
Mold 350 may comprise a variety of materials, such as metals, metallic alloys, one or more polymers or copolymers, ceramic materials, wood, stone, coral, or any combination thereof. Exemplary metallic matenals include, but are not limited to, aluminum and aluminum alloys. Exemplary polymer or co-polymer materials include, but are not limited to, polyoxymethylene (acetal copolymer), such as Delrin® acetal homopolymers produced by DuPont™ Any other polymer/copolymer materials suitable for providing a mold on which to cast a tissue expander according to the present disclosure may be used. - In some embodiments, a mirror image of a desired surface texture, such as a micro-texture or a nano-texture, may be imparted onto the upper surface 352 a and/or the lower surface 352 b of the
mold 350, so as to impart the desired surface texture on an expander. Various techniques may be used to texturize the upper surface 352 a and/or lower surface 352 b. Various systems and methods for texturizing surfaces of implant molds and mandrels are disclosed in U.S. App. No. 62/334,667, filed on May 11, 2016, and U.S. App. No. 62/410,121, filed on Oct. 19, 2016, which are incorporated by reference herein in their entireties. For example,mold 350 may be impacted (e.g., blasted or sandblasted) with an abrasive substance, such as a plurality of abrasive particles. Exemplary materials for the abrasive particles may include, but are not limited to, staurolite minerals, quartz, kyanite, titanium minerals and/or their alloys, zircon, heavy metals (e.g., cadmium, selenium, ferrous iron, and/or steel alloys such as tungsten alloys, chromium alloys, magnesium alloys, molybdenum alloys, and vanadium alloys). In some examples, the abrasive particles may be generally non-spherical in shape, e.g., irregular-shaped particles. For example, the particles may have a granular, irregular shape. In other examples, the abrasive particles may be generally spherical, ovoid, or otherwise regular in shape. In some examples, the abrasive particles may have generally rounded surfaces. In at least one example, the abrasive particles may comprise quartz, and may have generally rounded surfaces clean from extraneous debris, e.g., having less than about 7.0%, less than about 5.0%, less than about 3.0% free silica, or less than about 1.0% free silica. - The composition and shape of the particles may be selected based at least partially on the composition of the
mold 350, e.g., to provide for a difference in Mohs hardness between the abrasive particles and themold 350. In some examples, the abrasive particles may have a Mohs hardness ranging from 5.0 to 8.0, such as from 5.0 to 6.5, from 6.5 to 7.0, or from 7.0 to 8.0. For example, the abrasive particles may have a Mohs hardness that is 1-3 values greater than the material(s) of themold 350. - The average diameter of the abrasive particles may range from about 10 μm to about 500 μm, such as from about 50 μm to about 450 μm, from about 50 μm to about 250 μm, from about 50 μm to about 100 μm, or from about 75 μm to about 125 μm. In at least one example, the abrasive particles may comprise quartz with an average diameter ranging from about 50 μm to about 100 μm (e.g., a mesh screen size in the range of 50-100 μm).
- Abrasive particles may be blasted at the mold surface 352 a, 352 b from, for example, a nozzle. The distance between the nozzle and the mold surfaces 352 a, 352 b may also be adjusted to affect the surface texture. The distance between the nozzle and the mandrel surface may range from about 2 cm to about 75 cm, such as from about 5 cm to about 50 cm, from about 5 cm to about 25 cm, from about 25 cm to about 50 cm, from about 10 cm to about 35 cm, or from about 10 cm to about 25 cm.
- An expander may then be made by, e.g., coating the surface of
mold 350 with a material including, e.g., silicone, polyurethane, or a silicone-polyurethane co-polymer. The material may be allowed to set by, e.g., curing. Upon removal of the set material frommold 350, the material may be inverted, such that the portion of the material previously contacting the surface ofmold 350 forms the outermost surface of the expander. -
FIG. 4 (including close-upviews tissue expander system 400, includingexpander 401 andport 470, which are connected byconnector tube 430.Expander 401 comprises ashell 405 having ananterior side 402 a and aposterior side 402 b.Expander 401 may have a general size and shape similar to, and may include any of the features of,expanders expander 401 may includeridges 40 a, 406 b, 400 c, 406 d having shapes and configurations similar toridges 104 a. 104 b, 104 c ofexpander 100, andvalleys valleys expander 100.Expander assembly 401 may also include aport connection 410 similar toport connection 110. As depicted in close-upview 420,port connection 410 may include both abase 424 and aprotrusion 422, which may, fluidly connect to, e.g.,connector tube 430.Base 424 may be sealed to shell 405, e.g., by vulcanization or glue, or may be molded as a single piece withshell 405. - Bridges, e.g., bridges 404 a, 404 b, 404 c, 404 d, 404 e, 404 f, 404 g, 404 h may be circumferentially disposed around
anterior side 402 a ofexpander 401. Similar tobridges expander 300, each bridge may be a raised section of theshell 405 crossing a valley between two adjacent ridges in the shell. For example, bridge 404 g may be a raised portion ofshell 405crossing valley 407 b, betweenridges 406 a and 406 b. The bridges may be arranged in rows radiating in a direction radially outward from a point onanterior side 402 a. As with bridges ofexpander 300, bridges in a single row may cross alternating valleys. Adjacent rows of bridges may radiate outward fromanterior side 402 a at intervals of 60°. Bridges in adjacent rows may cross different alternating valleys; for example, the row ofbridges valleys bridges valleys expander 300. As withchannels bridges expander 401 may have a height across the valley it crosses so as to create a “break” in the valley and connect each ofridges expander 401 may travel between the ridges ofexpander 401 such that any forces exerted onexpander 401 are distributed across the surface ofexpander 401, promoting even expansion and contraction, and controlling wrinkling ofexpander 401. - As with
bridges expander 401 may be present in a variety of numbers and configurations. For example, as depicted inFIG. 4 , six rows of bridges may radiate outward fromanterior side 302 a, and the rows may be disposed aboutanterior side 302 a at equal intervals. In further embodiments, two, three, four five, seven, eight, or more rows of bridges may radiate outward onanterior side 302 a, at equal or unequal intervals. For example, a first pair of adjacent rows of bridges may be disposed at a 45° angle to one another, and a second pair of adjacent rows of bridges may be disposed at a 135° angle to one another. - In yet further embodiments, each row of bridges may include a bridge crossing every third valley or every fourth valley, as opposed to every other valley. In yet further embodiments, the bridges may not be arranged in rows, but rather may be circumferentially distributed around a point on
anterior side 402 a in a staggered formation. One of skill in the art will recognize that the bridges may be present in any number, configuration and placement that promotes even flow of fluid insideexpander 401 between each ofridges expander 401. As withexpanders expander 401 may promote uniform expansion ofexpander 401 upon introduction of more fluid insideexpander 401. -
Port 470 may include, as pictured inview 480, abase 482, aring 484, and acap 486, each of which may be made using one or more biocompatible materials, such as plastic (e.g., polyoxymethylene), silicone, or metal (e.g., titanium).Port 470 may be fluidly connected to expander 401 and may be configured to receive fluid for delivery into, or removal from,expander 401.Cap 486 may include an insertion point through which fluid may be received intoport 470, and anexit hole 488 through which fluid may be fed toexpander 401.Cap 486 may be made of, e.g., a self-sealing material that may be penetrated by a fluid delivery device, such as a needle that may deliver fluid.Ring 484 may be located belowcap 486 and may surround the insertion point incap 486.Ring 484 may include, e.g., a material that may resist penetration by a fluid delivery device, such as a metal or plastic material.Ring 484 may have anaperture 485 through which fluid introduced viacap 486 may travel to exithole 488.Base 482 may also include a material that may resist penetration by a fluid delivery device, such as a metal or plastic material.Base 482 may be affixed to ring 484 and/or cap 486 so as to create an enclosure into which fluid may be delivered throughcap 486, and out of which fluid may exit throughexit hole 488. -
Port 470 may be fluidly connected to expander 401 via, for example,connector tube 430.Connector tube 430 may include a lumen 462 (depicted in view 460) suitable for carrying fluid fromport 470 toport connection 410.Connector tube 430 may be made of one or more biocompatible materials suitable for implantation in a patient's body. In some embodiments,connector tube 430 may include any material suitable for inclusion inexpander 401. In some embodiments,connector tube 430 may have an inner or outer surface having a texture, such as any texture suitable for an inner or outer surface ofexpander 401. In some embodiments,connector tube 430 may be flexible, such that it may be bent into multiple configurations. In some embodiments,connector tube 430 may be kink resistant, such that it does not collapse and limit or prevent flow of fluids inside.Connector tube 430 may be any suitable length allowing for a desired placement ofexpander 401 andport 470.Connector tube 430 may be fluidly connected on one end to port 470 via, for example,exit hole 488, and may be fluidly connected on the other end to an opening into an interior ofexpander 401, such asport connection 410. In some embodiments,expander system 400 may include one or more valves (not pictured) which may restrict the flow of fluid out of or intoexpander 401. - In some embodiments,
port 470 may be connected directly toexpander 401 withoutconnector tube 430. In alternative embodiments,port 470 may be integrated intoshell 405 ofexpander 401. For example, a top ofport cap 486 may be approximately flush with a portion ofanterior side 402 a orposterior side 402 b ofexpander 401. In such embodiments,port 470 may be affixed to shell 405 in an opening inanterior side 402 a orposterior side 402 b ofexpander 401. - In some embodiments,
port 470 may include one or more features configured to facilitate locatingport 470 in cases whereport 470 may not be visible, such as whenport 470 is implanted internally in a patient. For example,port 470 may include an electromagnetic coil withinring 484 which may be centered around a needle insertion point incap 486, and which may be detectable using an electromagnetic signal detector, such as a radiofrequency reader. Detection of the electromagnetic coil may facilitate location of the needle insertion point. Additionally or alternatively, in some embodiments,port 470 may include one or more features configured to prevent over insertion of a needle throughcap 486, such as a reinforcedbase 482. Various systems and methods for assisting in locating ports and preventing needle over insertion into ports are disclosed in U.S. application Ser. No. 15/427,599, filed on Feb. 8, 2017, which is incorporated by reference herein in its entirety. - Expanders according to the present disclosure (including
expanders expanders FIGS. 1A-1B, 2A-2B, and 3A-3B . - Tissue expanders according to the present disclosure may be made in a variety of ways.
-
FIG. 5 depicts an exemplary method by which an expander according to the present disclosure may be manufactured. According to step 502, a mold may be coated with a liquid dispersion of a biocompatible material. According to step 504, the material coating the mold may be allowed to set or cure (e.g., by application of heat) to form a flexible expander shell. Accordingstep 506, the expander shell may be removed from the mold. According to step 508, the expander shell may be inverted, or turned inside out. According to step 510, the expander may be sealed. - According to step 502, a mold may be coated in a liquid dispersion of a material. In some embodiments, the mold may have an inverse of a shape and topography of a desired expander. For example,
mold 350 may be used to make an expander such asexpander 300. In other embodiments, the mold may have the same shape and topography as a desired expander. In further embodiments, the mold may be a hollow mold, the inside of which may be coated in a liquid dispersion (in which case the shell may not be inverted as discussed below). - The mold may be coated in a dispersion of any material suitable for use in the shell of the desired expander, such as a silicone, a polyurethane, a silicone or polyurethane copolymer, or a silicone and polyurethane copolymer. In some embodiments, the mold may be coated in a dispersion multiple times, so as to create a desired shell thickness. In some embodiments, the mold may be coated in multiple different dispersions, such as dispersions of both clear and colored silicone or other material.
- In some embodiments, the mold (such as mold 350) may be coated in a liquid dispersion using a dip-molding process. In other embodiments, a rotational molding process may be used.
- According to step 504, the material coating the mold may be allowed to set or cure into an expander shell. In embodiments in which a silicone or polyurethane polymer or co-polymer is used, for example, the material and mold may be cured together at a suitable temperature. For example, a mold coated with a silicone material may be cured at a temperature ranging from about 100° C. to about 200° C., such as from about 125° C. to about 175° C., or from about 125° C. to about 150° C. In some examples, the curing temperature may range from about 125° C. to about 127° C., e.g., about 125° C., about 126° C., or about 127° C. In further examples, the curing temperature may be about 150° C.
- According
step 506, the expander shell may be removed from the mold. In some embodiments, an aperture may exist or be created in the shell so as to remove the shell from the mold. According to step 508, the expander shell may then be inverted, or turned inside out. Thus, for example, in the case of a dipped mold, the surface of the shell formerly in contact with the mold (e.g., mold 350) may form an exterior surface of the shell having a texture and topography that is a mirror image of the surface of the mold. Alternatively, the cured shell may be removed from a mold, such as a rotational mold, and may not be turned inside out. - According to step 510, the expander shell may be sealed. For example, if an aperture existed or was created so as to remove the expander shell from the mold, such an aperture may be sealed using, e.g., vulcanization, glue, or other methods. In some examples, the expander shell may be sealed to a port or a port connector, through which fluid may be introduced into the expander. For example, the port or port connector may be coupled to, or incorporated into, the aperture of the shell used to remove the mold, or another aperture or opening created so as to accommodate the port or port connector. In some embodiments, a connector tube may be coupled to a port connector that is coupled to or otherwise incorporated into an aperture of the shell, and may be affixed using, e.g., vulcanization or glue. In further embodiments, a port or port connector connector may be removably coupled to a connector tube. The above-described process is exemplary in nature. Steps of this process may be performed in a different order, or removed altogether. In further embodiments, expanders according to the present disclosure may be made according to any way that is known to those of ordinary skill in the art.
- Expanders according to the present disclosure may be used in a variety of different procedures. For example, expanders according to the present disclosure may be useful in tissue reconstruction surgery and/or elective surgery for esthetic purposes, including minimally-invasive surgery. For example, the expanders of the present disclosure may include a flexible, elastic shell that allows the expanders to be folded or rolled prior to insertion into patient tissue, thus allowing them to be inserted through a relatively small incision. The elasticity and/or surface features of the expanders disclosed herein may allow the expanders to roll and unroll, fold and unfold, and/or expand and contract in a controlled, predictable fashion, thus allowing for control and predictability of the expanders' behavior upon implantation in a patient. Additionally, the topographies of expanders disclosed herein may provide a structure and/or shape to which the expanders may return more easily, thus helping to avoid unwanted wrinkling or creasing of the expanders. The expanders may be inserted into a patient without fluid (e.g., to be filled after insertion) or partially filled with fluid (e.g., to be additionally filled after insertion).
- As has been previously discussed herein, expanders according to the present disclosure (such as
expanders expander 100 inFIGS. 6A-6C .FIG. 6A depicts, for example,expander 100 in a contracted form. For example,expander 100 may be inserted into a patient while in the contracted form.FIG. 6B depicts, for example,expander 100 in a partially expanded form, such as when some fluid has been introduced intoexpander 100, e.g., following insertion into the patient.FIG. 6C depicts, for example,expander 100 in more fully expanded form, when additional fluid has been introduced intoexpander 100, e.g., after theexpander 100 has been implanted for a period of time to allow for gradual tissue expansion. As mentioned above, any suitable fluid may be used, including, but not limited to, water, saline solution (or other biocompatible solution), silicone gel (or other biocompatible gel), or air (or other biocompatible gas, e.g., nitrogen). Tissue expansion may occur over the span of weeks to months, e.g., from about 4 weeks to about 24 weeks, or from about 6 weeks to about 8 weeks. e.g., about 4, 6, 8, 10, 12, 14, 16, 20, 22, or 24 weeks or more. The fluid may be at least partially or completely removed fromexpander 100, e.g., viaport connector 110, prior to removal from the patient once sufficient tissue expansion has been achieved. - Any aspect or feature in any embodiment may be used with any other embodiment set forth herein. It will be apparent to those skilled in the art that various modifications and variations can be made in the disclosed implants, implant features, and processes without departing from the scope of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification and practice of the disclosure disclosed herein. It is intended that the specification and examples be considered as exemplary only. Other aspects and embodiments of the present disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the embodiments disclosed herein.
Claims (21)
1-30. (canceled)
31. An implantable medical device comprising:
a flexible shell defining a cavity and having a posterior side and an anterior side;
a fluid disposed within the cavity;
a plurality of ridges extending circumferentially about an apex of the anterior side of the flexible shell, each ridge curving in an arc from a first end to a second end;
wherein the plurality of ridges are disposed in an alternating arrangement with a valley between adjacent ridges; and
at least one channel traversing the valley to connect two adjacent ridges.
32. The implantable medical device of claim 1, wherein the at least one channel extends radially outward from the apex.
33. The implantable medical device of claim 1, wherein the at least one channel includes:
two or more channels that are circumferentially spaced about the apex.
34. The implantable medical device of claim 1, wherein the plurality of ridges includes at least three ridges, further comprising:
a first channel connecting a first ridge to a second ridge adjacent to the first ridge and the first channel traversing the valley therebetween; and
a second channel connecting the second ridge to a third ridge and the second channel traversing the valley connected therebetween;
wherein the first channel, the second channel and the apex are not co-linear.
35. The implantable medical device of claim 1, wherein the flexible shell has a uniform thickness.
36. The implantable medical device of claim 1, wherein the flexible shell has a varied thickness.
37. The implantable medical device of claim 1, wherein the flexible shell is formed from at least one layer.
38. The implantable medical device of claim 1, wherein the flexible shell is formed from at least one biocompatible material;
wherein the at least one biocompatible material is elastic and configured to maintain its shape after contraction.
39. The implantable medical device of claim 8, wherein the at least one biocompatible material includes at least one of silicone, polyurethane, polyurethane blends, polymers, polyethylene terephthalate, polyether block amide, or polyamide-12.
40. The implantable medical device of claim 1, wherein the fluid is a biocompatible gel.
41. The implantable medical device of claim 1, wherein at least a portion of the flexible shell includes at least one texture.
42. An implantable medical device comprising:
a flexible shell including:
an outermost surface;
a plurality of layers;
wherein each of the plurality of layers is formed from an elastic, biocompatible material configured to maintain its shape after contraction;
a posterior side and an anterior side;
the flexible shell defining a cavity; and
a plurality of ridges spaced around the outermost surface of the flexible shell, each ridge curving along the outermost surface of the flexible shell and forming an arc between a first end of each of the plurality of ridges and a second end of each of the plurality of ridges;
wherein the plurality of ridges and a plurality of valleys are disposed in an alternating arrangement; and
a biocompatible fluid disposed within the cavity.
43. The implantable medical device of claim 12, wherein the outermost surface is at least partially textured.
44. The implantable medical device of claim 12, wherein the flexible shell has a uniform thickness.
45. The implantable medical device of claim 12, wherein the flexible shell has a varied thickness.
46. The implantable medical device of claim 12, wherein each ridge of the plurality of ridges has a variable height or the plurality of valleys has variable depth.
47. The implantable medical device of claim 12, further comprising:
at least one channel traversing the valley and configured to connect two adjacent ridges.
48. The implantable medical device of claim 12, wherein each ridge is concentric.
49. An implantable medical device comprising:
a flexible shell defining a cavity, the flexible shell including:
an outer surface having a topography including:
a plurality of concentric ridges disposed circumferentially about an apex; and
a valley separating two adjacent ridges;
at least one layer formed from a first biocompatible material; and
a second biocompatible material disposed within the cavity.
50. The implantable medical device of claim 19, wherein the flexible shell formed from an elastic material configured to maintain its shape after contraction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/084,041 US20230270517A1 (en) | 2016-10-28 | 2022-12-19 | Tissue expanders and methods of use thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662414269P | 2016-10-28 | 2016-10-28 | |
PCT/IB2017/001449 WO2018078446A1 (en) | 2016-10-28 | 2017-10-27 | Tissue expanders, methods of manufacturing and molds thereof |
US201916345261A | 2019-04-26 | 2019-04-26 | |
US18/084,041 US20230270517A1 (en) | 2016-10-28 | 2022-12-19 | Tissue expanders and methods of use thereof |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/345,261 Continuation US11571271B2 (en) | 2016-10-28 | 2017-10-27 | Tissue expanders and methods of use thereof |
PCT/IB2017/001449 Continuation WO2018078446A1 (en) | 2016-10-28 | 2017-10-27 | Tissue expanders, methods of manufacturing and molds thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230270517A1 true US20230270517A1 (en) | 2023-08-31 |
Family
ID=60782255
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/345,261 Active 2038-07-27 US11571271B2 (en) | 2016-10-28 | 2017-10-27 | Tissue expanders and methods of use thereof |
US18/084,041 Pending US20230270517A1 (en) | 2016-10-28 | 2022-12-19 | Tissue expanders and methods of use thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/345,261 Active 2038-07-27 US11571271B2 (en) | 2016-10-28 | 2017-10-27 | Tissue expanders and methods of use thereof |
Country Status (7)
Country | Link |
---|---|
US (2) | US11571271B2 (en) |
EP (1) | EP3531956A1 (en) |
KR (2) | KR20220084211A (en) |
CN (2) | CN116327379A (en) |
CA (1) | CA3041435A1 (en) |
IL (2) | IL265954B2 (en) |
WO (1) | WO2018078446A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9050184B2 (en) | 2008-08-13 | 2015-06-09 | Allergan, Inc. | Dual plane breast implant |
US20100249924A1 (en) | 2009-03-27 | 2010-09-30 | Allergan, Inc. | Bioerodible matrix for tissue involvement |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US10123868B2 (en) * | 2011-10-19 | 2018-11-13 | Hilton Becker | Hybrid breast implant, method for making and using same |
WO2014093669A1 (en) | 2012-12-13 | 2014-06-19 | Allergan, Inc. | Device and method for making a variable surface breast implant |
WO2015058051A1 (en) | 2013-10-18 | 2015-04-23 | Mcclellan William T | Tissue expander improvements |
US11883275B2 (en) | 2014-06-11 | 2024-01-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
GB201521474D0 (en) | 2015-12-04 | 2016-01-20 | Univ Manchester | Textured surfaces for implants |
IL305116A (en) * | 2016-05-11 | 2023-10-01 | Estab Labs S A | Medical implants and methods of preparation thereof |
CA3041435A1 (en) | 2016-10-28 | 2018-05-03 | Establishment Labs S.A. | Tissue expanders, methods of manufacturing and molds thereof |
US11039898B2 (en) * | 2018-02-08 | 2021-06-22 | William T. MCCLELLAN | MRI safe tissue expander port |
US11759306B2 (en) | 2018-03-12 | 2023-09-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11207149B2 (en) | 2018-05-17 | 2021-12-28 | William T. MCCLELLAN | Thermal MRI safe tissue expander port |
US10660742B2 (en) * | 2018-05-17 | 2020-05-26 | Biosense Webster (Israel) Ltd. | Expandable breast implant |
US10898313B2 (en) * | 2018-08-10 | 2021-01-26 | Mentor Worldwide Llc | Systems, devices and methods of making mammary implants and tissue expanders having ribbed shells |
GB2583133B (en) | 2019-04-18 | 2021-10-20 | Azhar Aslam Mohammad | Breast implant with radially extending ridges |
USD931460S1 (en) | 2019-08-01 | 2021-09-21 | Mentor Worldwide Llc | Implant shell having internal, global ribs |
USD905855S1 (en) | 2019-08-01 | 2020-12-22 | Mentor Worldwide Llc | Implant shell having internal, circumferential ribs |
BR122023022155A2 (en) | 2020-03-23 | 2024-02-20 | Bard Shannon Limited | IMPLANTABLE PROSTHESIS COMPRISING A BODY OF BIOCOMPATIBLE MATERIAL |
US11471268B2 (en) | 2020-04-25 | 2022-10-18 | Mentor Worldwide Llc | Implants having gel zones with higher levels of cohesiveness for eschewing scalloping, dimpling, and wrinkling |
CN113855267A (en) * | 2021-11-05 | 2021-12-31 | 重庆市璧山区人民医院 | Skin expander convenient to adjust |
Family Cites Families (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4574780A (en) | 1984-11-13 | 1986-03-11 | Manders Ernest K | Tissue expander and method |
US4671255A (en) | 1985-10-16 | 1987-06-09 | Mcghan Medical Corporation | Tissue expander with self-contained injection reservoir and reinforcing insert |
US6228116B1 (en) | 1987-12-22 | 2001-05-08 | Walter J. Ledergerber | Tissue expander |
US5282856A (en) * | 1987-12-22 | 1994-02-01 | Ledergerber Walter J | Implantable prosthetic device |
US4955907A (en) * | 1987-12-22 | 1990-09-11 | Ledergerber Walter J | Implantable prosthetic device |
US4950292A (en) | 1988-04-20 | 1990-08-21 | Dow Corning Corporation | Tissue expanders |
US5171269A (en) * | 1991-08-29 | 1992-12-15 | Medical Engineering Corporation | Mammary prosthesis |
US5146933A (en) | 1991-09-20 | 1992-09-15 | Dow Corning Wright Corporation | Implantable prosthetic device and tethered inflation valve for volume |
US5716407A (en) | 1992-08-24 | 1998-02-10 | Lipomatrix, Incorporated | Method of rendering identifiable a living tissue implant using an electrical transponder marker |
ES2159316T3 (en) | 1994-03-31 | 2001-10-01 | Ernest C Manders | DIMENSIONALLY ADJUSTABLE SOFT FABRIC EXTENSIONER. |
US6071309A (en) | 1995-03-22 | 2000-06-06 | Knowlton; Edward W. | Segmental breast expander for use in breast reconstruction |
US6055989A (en) | 1996-03-21 | 2000-05-02 | Robert D. Rehnke | Method for surgical dissection, sizing and expansion |
US5913871A (en) | 1996-09-25 | 1999-06-22 | Medtronic, Inc. | Balloon modification for improved stent fixation and deployment |
US5776159A (en) | 1996-10-03 | 1998-07-07 | General Surgical Innovations, Inc. | Combination dissector and expander |
US5935164A (en) | 1997-02-25 | 1999-08-10 | Pmt Corporaton | Laminated prosthesis and method of manufacture |
US20010004709A1 (en) | 1998-06-09 | 2001-06-21 | William R. Dubrul | Tissue expander apparatus with magnetically locatable injection site and methods for use |
WO2001030272A1 (en) | 1999-10-22 | 2001-05-03 | Miller Archibald S | Breast implant |
US6588432B1 (en) | 2001-02-15 | 2003-07-08 | Pmt Corporation | Tissue expander magnetic injection port |
US7572270B2 (en) | 2001-02-16 | 2009-08-11 | Cordis Corporation | Balloon catheter stent delivery system with ridges |
US6605116B2 (en) | 2001-04-03 | 2003-08-12 | Mentor Corporation | Reinforced radius mammary prostheses and soft tissue expanders |
US20030144734A1 (en) | 2002-01-28 | 2003-07-31 | Dreschnack Paul A. | Breast implant with locatable injection site |
US6743254B2 (en) | 2002-02-01 | 2004-06-01 | Mentor Corporation | Tissue expander with protection against accidental puncture |
US6875233B1 (en) | 2003-06-10 | 2005-04-05 | Hinging breast implant | |
US7650848B2 (en) * | 2004-02-17 | 2010-01-26 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
US9526584B2 (en) | 2004-09-21 | 2016-12-27 | Airxpanders, Inc. | Tissue expanders, implants, and methods of use |
US7081136B1 (en) | 2005-04-18 | 2006-07-25 | Techno Investments Llc | Adjustable gel filled mammary prosthesis and method |
WO2007000756A2 (en) | 2005-06-28 | 2007-01-04 | Ami Glicksman | Human implantable tissue expander |
USD605767S1 (en) | 2007-01-24 | 2009-12-08 | Dessington de Beer | Mammary prosthesis |
US20080188923A1 (en) * | 2007-02-01 | 2008-08-07 | Jack Fa-De Chu | Endovascular devices to protect aneurysmal wall |
US7731700B1 (en) | 2007-06-29 | 2010-06-08 | Walter Samuel Schytte | Subdermal injection port |
CA124999S (en) | 2007-09-07 | 2009-11-02 | Gary Pierre Lauryssen | Mammary prosthesis |
USD604849S1 (en) | 2007-12-06 | 2009-11-24 | Gary Pierre Lauryssen | Mammary prosthesis |
US8398710B2 (en) | 2008-01-31 | 2013-03-19 | Milux Holding Sa | Breast implant system |
US7753954B2 (en) | 2008-04-11 | 2010-07-13 | American Breast Care LP | Breast prosthesis for patients with edema |
CA2733925C (en) | 2008-08-13 | 2019-01-15 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US8506627B2 (en) | 2008-08-13 | 2013-08-13 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
EP2361101A2 (en) | 2008-10-17 | 2011-08-31 | Allergan, Inc. | Prosthetic implant shell |
EP2453839B1 (en) | 2009-07-17 | 2014-03-12 | Kirk Promotion LTD. | Breast implant system |
US9017403B2 (en) | 2009-07-17 | 2015-04-28 | Peter Forsell | Breast implant system |
EP2467175B1 (en) | 2009-08-18 | 2015-02-25 | Allergan, Inc. | Reinforced prosthetic implant with flexible shell |
US8167836B2 (en) | 2009-12-08 | 2012-05-01 | Taris Biomedical, Inc. | Tissue expander configured for drug delivery |
CA3018101C (en) | 2009-12-18 | 2022-03-01 | Airxpanders, Inc. | Tissue expanders and methods of use |
US8454690B2 (en) | 2009-12-22 | 2013-06-04 | William T. MCCLELLAN | Systems and methods for tissue expansion with fluid delivery and drainage system |
EP2554138A1 (en) | 2010-02-05 | 2013-02-06 | Allergan, Inc. | Inflatable prostheses and methods of making same |
US8636797B2 (en) | 2010-02-05 | 2014-01-28 | Allergan, Inc. | Inflatable prostheses and methods of making same |
US10792141B2 (en) * | 2010-10-04 | 2020-10-06 | Blockhead Of Chicago, Llc | Soft tissue implant and method of using same |
US8597239B2 (en) * | 2011-03-01 | 2013-12-03 | Sanovas, Inc. | Abrading balloon catheter for extravasated drug delivery |
US8852276B2 (en) | 2011-07-05 | 2014-10-07 | Lipovera, Llc | Cosmetic surgery sizer |
US10123868B2 (en) * | 2011-10-19 | 2018-11-13 | Hilton Becker | Hybrid breast implant, method for making and using same |
EP3400900B1 (en) | 2012-01-13 | 2020-05-20 | LifeCell Corporation | Methods of manufacturing breast prostheses |
TWI636771B (en) | 2012-05-29 | 2018-10-01 | 鄭孝胥 | Human tissue radiation protector and auxiliary method of radiation therapy |
US9814566B1 (en) | 2012-08-15 | 2017-11-14 | Pmt Corporation | Tissue expander injection assemblies |
US10820984B2 (en) | 2012-11-14 | 2020-11-03 | ImplantADJUST, LLC | Implant with elastomeric membrane and methods of fabrication thereof |
US8821574B2 (en) | 2012-12-05 | 2014-09-02 | Mentor Worldwide Llc | Valve assemblies for expandable implants and tissue expanders |
US8870952B2 (en) | 2012-12-06 | 2014-10-28 | Ethicon, Inc. | Valve assemblies for implantable prostheses and tissue expanders |
CN105142572B (en) | 2013-01-30 | 2018-05-11 | 因普利特有限公司 | The implantable tissue expander of the mankind |
US9700404B2 (en) | 2013-03-14 | 2017-07-11 | Ethicon, Inc. | Tissue expander implant with self-sealing safety patch |
WO2014168926A1 (en) | 2013-04-09 | 2014-10-16 | Reconstructive Technologies, Llc | Systems and methods for a tissue expander |
US9399122B2 (en) | 2013-04-09 | 2016-07-26 | Reconstructive Technologies, Llc | Systems and methods for a tissue expander |
WO2015058051A1 (en) | 2013-10-18 | 2015-04-23 | Mcclellan William T | Tissue expander improvements |
US9700405B2 (en) | 2014-03-31 | 2017-07-11 | Mentor Worldwide Llc | Directional tissue expander |
US9463087B2 (en) | 2014-03-31 | 2016-10-11 | Mentor Worldwide Llc | Directional tissue expander |
WO2015176014A1 (en) | 2014-05-16 | 2015-11-19 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US9636210B2 (en) | 2014-05-19 | 2017-05-02 | Mentor Worldwide Llc | Injection zone markers for biomedical implants |
FR3023158A1 (en) | 2014-07-07 | 2016-01-08 | Souheil Baccache | FIXING OF MAMMARY PROSTHESIS BY TABS |
US10799313B2 (en) | 2015-03-12 | 2020-10-13 | Mentor Worldwide Llc | Tissue expander with pectoral attachment |
US20150245903A1 (en) | 2015-05-14 | 2015-09-03 | Hilton Becker | Tissue expander |
ITUB20152200A1 (en) | 2015-07-15 | 2017-01-15 | Solidago Ag | SELF-SUPPORTING PROSTHESIS FOR PLASTIC AND RECONSTRUCTIVE SURGERY INTERVENTIONS |
US10709851B2 (en) | 2015-10-29 | 2020-07-14 | Sientra, Inc. | Systems, methods and devices for subcutaneous target location |
US20170348089A1 (en) | 2016-06-07 | 2017-12-07 | Techno Investments, Llc | Adjustable breast implant with integral injection port |
CA3041435A1 (en) | 2016-10-28 | 2018-05-03 | Establishment Labs S.A. | Tissue expanders, methods of manufacturing and molds thereof |
US10751163B2 (en) | 2017-09-01 | 2020-08-25 | Mentor Worldwide Llc | Adjustable implant |
US10751164B2 (en) | 2017-11-28 | 2020-08-25 | Biosense Webster (Israel) Ltd. | Inelastic noiseless air bag in a breast implant |
EP3494926A1 (en) | 2017-12-05 | 2019-06-12 | Repuls Lichtmedizinteckhnik GmbH | Implant with reservoir |
US11039898B2 (en) | 2018-02-08 | 2021-06-22 | William T. MCCLELLAN | MRI safe tissue expander port |
US11154393B2 (en) | 2018-02-09 | 2021-10-26 | Tepha, Inc. | Full contour breast implant |
USD889655S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
US11382709B2 (en) | 2018-02-09 | 2022-07-12 | Mentor Worldwide Llc | Tissue expander |
USD889654S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
US10799337B2 (en) | 2018-03-09 | 2020-10-13 | Biosense Webster (Israel) Ltd. | Impermeable inner shell for a breast implant |
KR20210009302A (en) | 2018-03-13 | 2021-01-26 | 플라비오 나니 | A mesh or membrane covering made of a biological or biosynthetic material for the prosthesis and comprising a system for fixation on the prosthesis, and a method for manufacturing the corresponding |
US11207149B2 (en) | 2018-05-17 | 2021-12-28 | William T. MCCLELLAN | Thermal MRI safe tissue expander port |
US10660742B2 (en) | 2018-05-17 | 2020-05-26 | Biosense Webster (Israel) Ltd. | Expandable breast implant |
KR102144312B1 (en) | 2018-06-18 | 2020-08-14 | 서울대학교병원 | Tissue expander for breast reconstruction |
USD892329S1 (en) | 2018-07-03 | 2020-08-04 | Tepha, Inc. | Three dimensional mastopexy implant |
US10898313B2 (en) | 2018-08-10 | 2021-01-26 | Mentor Worldwide Llc | Systems, devices and methods of making mammary implants and tissue expanders having ribbed shells |
USD896383S1 (en) | 2018-09-13 | 2020-09-15 | Allergan, Inc. | Tissue expansion device |
CA3112634A1 (en) | 2018-09-13 | 2020-03-19 | Allergan, Inc. | Tissue expansion device |
US11779455B2 (en) | 2018-10-02 | 2023-10-10 | Tepha, Inc. | Medical devices to limit movement of breast implants |
US11259913B2 (en) | 2019-02-06 | 2022-03-01 | Susan Scott | Breast implant with position marker |
US11273027B2 (en) | 2019-02-08 | 2022-03-15 | Carla J. NYGAARD | Device and method for an implant |
US11648104B2 (en) | 2019-05-10 | 2023-05-16 | Allergan, Inc. | Implant identification by radiographic means |
WO2020236989A1 (en) | 2019-05-20 | 2020-11-26 | Reconstructive Technologies, Llc | Systems and methods for a tissue expander |
KR102338402B1 (en) | 2019-09-06 | 2021-12-13 | 오스템임플란트 주식회사 | Tissue expander with inlet having micro bubbles |
KR102294489B1 (en) | 2019-10-02 | 2021-08-27 | 건양대학교 산학협력단 | Patient-Specific Breast Implant for the Breast Reconstruction Following Breast Conserving Surgery |
JP2023523286A (en) | 2020-04-24 | 2023-06-02 | アラーガン、インコーポレイテッド | Drainable tissue expansion device |
-
2017
- 2017-10-27 CA CA3041435A patent/CA3041435A1/en active Pending
- 2017-10-27 KR KR1020227020093A patent/KR20220084211A/en active IP Right Grant
- 2017-10-27 WO PCT/IB2017/001449 patent/WO2018078446A1/en unknown
- 2017-10-27 IL IL265954A patent/IL265954B2/en unknown
- 2017-10-27 KR KR1020197012393A patent/KR102479359B1/en active IP Right Grant
- 2017-10-27 CN CN202211677796.5A patent/CN116327379A/en active Pending
- 2017-10-27 US US16/345,261 patent/US11571271B2/en active Active
- 2017-10-27 IL IL307400A patent/IL307400A/en unknown
- 2017-10-27 CN CN201780063706.4A patent/CN109843210B/en active Active
- 2017-10-27 EP EP17818254.9A patent/EP3531956A1/en active Pending
-
2022
- 2022-12-19 US US18/084,041 patent/US20230270517A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3531956A1 (en) | 2019-09-04 |
IL265954B1 (en) | 2023-11-01 |
CN109843210A (en) | 2019-06-04 |
CN109843210B (en) | 2023-01-17 |
IL307400A (en) | 2023-12-01 |
KR20190075940A (en) | 2019-07-01 |
US20190290382A1 (en) | 2019-09-26 |
CA3041435A1 (en) | 2018-05-03 |
US11571271B2 (en) | 2023-02-07 |
KR20220084211A (en) | 2022-06-21 |
IL265954A (en) | 2019-05-30 |
IL265954B2 (en) | 2024-03-01 |
CN116327379A (en) | 2023-06-27 |
WO2018078446A1 (en) | 2018-05-03 |
KR102479359B1 (en) | 2022-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230270517A1 (en) | Tissue expanders and methods of use thereof | |
US11857409B2 (en) | Medical implants and methods of preparation thereof | |
TWI781131B (en) | Device for fixation in a body lumen | |
US10765501B2 (en) | Dual plane breast implant | |
JP2020072872A (en) | Internal artificial organ | |
CN103997988B (en) | There is between inner housing in aqueous fluids environment the breast implant of low-friction coefficient | |
US5146933A (en) | Implantable prosthetic device and tethered inflation valve for volume | |
AU2009282389B2 (en) | Soft filled prosthesis shell with discrete fixation surfaces | |
US8506627B2 (en) | Soft filled prosthesis shell with discrete fixation surfaces | |
AU2010284503A1 (en) | Reinforced prosthetic implant with flexible shell | |
KR20160142349A (en) | Directional tissue expander | |
EP2854707B1 (en) | Dual plane breast implant | |
WO2015153065A1 (en) | Directional tissue expander | |
CN104661618B (en) | Valve | |
KR102294489B1 (en) | Patient-Specific Breast Implant for the Breast Reconstruction Following Breast Conserving Surgery | |
JP2024504175A (en) | 3D shaped skirt for artificial heart valves | |
WO2013037005A4 (en) | Prosthetic valve | |
BR112019007293B1 (en) | TISSUE EXPANDERS, MANUFACTURING METHODS AND MOLDS THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ESTABLISHMENT LABS S.A., COSTA RICA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARTINEZ, NICOLE;ARAUJO, NATHALIA;DE MEZERVILLE, ROBERTO;AND OTHERS;SIGNING DATES FROM 20190328 TO 20190504;REEL/FRAME:063310/0312 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |